Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3028531	s-nse	ug/l (ug/l)	4441	8556	0.05%
3028531	s-nse	— (—)	175	197	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal findings on diagnostic imaging of lung

1554

1906

8.45

307.65

1.7

1.9

19.25

28.17

ug/l

4.05

1525

1860

Malignant neoplasm

1530

1199

7.76

307.65

2.4

1.3

25.18

23.23

ug/l

0.30

1507

1169

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

339

255

14.03

307.65

2.4

1.3

20.65

19.03

ug/l

0.25

333

248

Malignant neoplasm of bronchus and lung

1063

755

14.95

307.65

2.3

1.7

31.55

19.83

ug/l

4.53

1047

736

Non-small cell lung cancer

920

694

15.21

307.65

1.8

17.88

25.29

ug/l

2.33

913

674

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1476

1019

8.77

307.65

2.4

1.4

25.24

22.77

ug/l

0.35

1454

993

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1442

429

32.36

307.65

2.1

1.3

30.66

19.32

ug/l

4.03

1424

413

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1372

370

35.98

307.65

2.1

1.3

31.38

19.89

ug/l

3.50

1355

356

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1651

720

21.90

307.65

2.4

1.3

29.09

24.47

ug/l

0.52

1623

699

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

920

286

35.00

307.65

1.8

1.3

17.88

21.12

ug/l

0.54

913

277

Lung cancer and mesothelioma

1392

506

27.72

307.65

2.1

2.0

30.98

20.75

ug/l

3.77

1374

494

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

634

321

21.59

307.65

2.2

1.3

34.15

21.25

ug/l

2.47

621

311

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1680

2298

7.09

307.65

1.7

2.0

19.63

27.41

ug/l

3.94

1646

2246

COPD (mode)

665

799

6.86

307.65

1.9

2.0

22.02

21.74

ug/l

0.04

652

780

Any event in cancer register

1371

1383

6.00

307.65

2.5

1.4

25.19

23.74

ug/l

0.22

1348

1352

Oxycodone

964

1493

6.55

307.65

2.2

1.8

31.08

23.47

ug/l

1.97

945

1454

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

342

41.23

307.65

1.7

1.2

16.22

15.33

ug/l

0.38

337

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1088

446

27.44

307.65

2.5

1.3

30.11

20.15

ug/l

3.21

1071

431

Other medical care

1159

1695

7.03

307.65

2.1

1.8

32.01

22.49

ug/l

3.17

1144

1651

Malignant neoplasm of respiratory system and intrathoracic organs

1132

858

13.63

307.65

2.2

1.7

30.83

20.18

ug/l

4.21

1115

836

Malignant neoplasm, wide definition for exclusion

1473

1019

8.75

307.65

2.4

1.4

25.26

22.77

ug/l

0.35

1451

993

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1473

1018

8.76

307.65

2.4

1.4

25.26

22.77

ug/l

0.35

1451

992

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

594

492

7.63

307.65

2.3

1.3

23.10

19.63

ug/l

0.56

581

480

Neoplasms

786

625

6.82

307.65

2.4

1.4

25.04

20.96

ug/l

0.91

777

614

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

752

712

8.50

307.65

2.3

1.3

20.11

21.15

ug/l

0.16

737

690

Persons encountering health services for specific procedures and health care

1382

2706

3.21

297.53

2.0

1.9

27.29

22.73

ug/l

1.42

1350

2653

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

566

481

7.30

297.50

2.4

1.3

23.54

19.46

ug/l

0.67

554

469

Other diseases of pleura

873

2144

3.72

258.74

1.7

1.9

23.31

23.69

ug/l

0.06

849

2097

Pleural effusion

415

714

6.15

231.69

1.6

1.9

20.44

23.55

ug/l

0.58

403

699

Later onset COPD, excluding more controls

411

519

6.42

219.31

1.9

20.11

20.03

ug/l

0.01

403

505

Pneumonias (Asthma/COPD co-morbidities)

1210

2998

2.83

219.01

2.0

22.39

25.74

ug/l

1.09

1183

2937

Pneumonia, organism unspecified

1143

2891

2.90

218.21

2.0

1.9

21.60

25.46

ug/l

1.45

1118

2832

COPD

833

2042

3.46

217.65

1.9

22.09

24.56

ug/l

0.58

815

1990

All pneumoniae

1201

3004

2.79

211.94

2.0

22.45

25.71

ug/l

1.05

1174

2944

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1188

3031

2.79

210.04

1.9

22.23

25.71

ug/l

1.16

1161

2970

Other chronic obstructive pulmonary disease

795

1998

3.40

202.85

1.9

21.56

24.73

ug/l

0.83

779

1946

First line medication for Crohn's disease

1245

2504

2.74

197.89

2.1

1.8

23.17

26.16

ug/l

0.78

1215

2454

Other chronic obstructive pulmonary disease, including avohilmo

887

2440

3.10

195.11

1.8

1.9

24.67

24.26

ug/l

0.06

871

2381

Influenza and pneumonia

1196

2953

2.69

194.74

2.0

1.9

22.38

25.56

ug/l

1.01

1170

2893

1086

2419

2.85

193.02

2.0

1.9

22.50

24.65

ug/l

0.60

1061

2370

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1086

2419

2.85

193.02

2.0

1.9

22.50

24.65

ug/l

0.60

1061

2370

Benign neoplasm of colon, rectum, anus and anal canal

498

756

4.77

192.25

1.7

1.3

22.80

22.60

ug/l

0.01

486

738

Other bacterial diseases

1169

3083

2.66

187.58

2.1

1.9

25.35

25.06

ug/l

0.05

1132

3030

COPD, early/later onset

804

2185

3.19

186.10

1.8

1.9

22.30

24.41

ug/l

0.46

788

2128

COPD, hospital admissions

799

2177

3.19

185.06

1.8

1.9

21.48

24.75

ug/l

0.85

783

2120

Early onset COPD, excluding more controls

350

631

5.71

184.56

1.8

2.1

25.16

24.49

ug/l

0.05

342

619

Any gastric operation

721

994

3.67

175.66

2.3

1.5

23.41

30.52

ug/l

1.13

707

978

GASTRO-related operations

721

994

3.67

175.66

2.3

1.5

23.41

30.52

ug/l

1.13

707

978

Bacterial infection, other or unspecified

777

2359

3.03

169.04

2.2

1.8

24.01

23.59

ug/l

0.08

758

2311

Excluding asthma or asthma-COPD overlap

792

1206

3.32

167.53

2.0

24.94

22.91

ug/l

0.34

780

1184

Benign neoplasm: Colon

437

734

4.63

167.31

1.7

1.3

23.96

22.78

ug/l

0.09

428

716

Cardiac arrest

241

266

8.40

166.49

1.9

1.8

30.02

22.99

ug/l

0.91

232

258

COPD differential diagnosis

779

1213

3.25

159.41

2.0

24.87

22.92

ug/l

0.32

768

1191

ILD differential diagnosis

779

1213

3.25

159.40

2.0

24.87

22.92

ug/l

0.32

768

1191

Benign neoplasms

505

692

4.16

151.86

2.1

1.4

25.12

20.14

ug/l

0.89

499

677

Asthma, unspecified (mode), excluding more controls

499

1037

3.82

151.30

1.8

2.0

19.46

22.88

ug/l

0.76

490

1023

Asthma, unspecified (mode)

510

1107

3.69

147.86

1.8

2.0

19.32

22.87

ug/l

0.85

501

1085

malignant neoplasm of male genital organs

754

1725

2.85

132.82

2.2

1.7

22.92

25.17

ug/l

0.38

740

1691

Other pulmonary diagnosis

717

1206

3.00

130.14

2.0

23.49

22.91

ug/l

0.09

707

1184

COPD, hospital admission 2, with asthma infections

535

1475

3.17

123.63

1.9

1.8

21.89

26.00

ug/l

0.78

524

1433

Other pleural conditions

231

415

5.84

123.24

1.5

2.0

24.06

25.02

ug/l

0.07

225

406

COPD related to multimorbidity

624

1861

2.89

122.33

1.8

1.9

23.31

24.55

ug/l

0.19

609

1809

Secondary uncertain malignant neoplasm

271

576

4.91

119.38

2.0

27.06

23.92

ug/l

0.42

265

566

Malignant neoplasm of prostate

724

1715

2.73

118.22

2.3

1.7

23.36

25.11

ug/l

0.27

711

1680

Malignant neoplasm of digestive organs

593

2120

2.81

115.07

2.3

1.8

19.46

24.40

ug/l

2.73

579

2063

Opioids

926

2066

2.37

109.98

2.0

1.8

24.90

22.03

ug/l

0.65

907

2021

Colorectal cancer, excluding all cancers (controls excluding all cancers)

257

533

4.74

109.83

1.9

1.3

18.11

19.37

ug/l

0.26

249

514

Asthma, excluding more controls

603

1109

2.92

107.11

1.9

2.0

19.78

22.86

ug/l

0.74

591

1095

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

199

357

5.69

105.51

2.1

1.3

18.57

20.69

ug/l

0.34

194

344

COPD, hospital admissions 3, with asthma pneumonia sepsis

454

1245

3.18

105.39

1.9

1.8

20.85

25.56

ug/l

1.04

445

1208

Asthma

620

1194

2.81

103.05

1.9

2.0

19.57

22.96

ug/l

0.91

608

1172

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

67.80

102.83

4.4

1.3

27.11

16.86

ug/l

0.80

Fever of other and unknown origin

614

2219

2.60

101.71

2.1

1.9

20.74

24.36

ug/l

1.36

596

2175

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1000

3428

2.11

97.72

1.9

23.56

25.02

ug/l

0.26

969

3370

Oral corticosteroids

1069

3152

2.07

95.49

1.8

2.0

22.66

25.66

ug/l

0.80

1042

3092

Chronic lower respiratory diseases

1147

3100

2.02

93.01

1.9

2.0

22.45

25.67

ug/l

0.86

1125

3035

ILD medications: prednisolone, methylprednisolone, prednisone

1071

2975

2.05

91.84

1.8

2.0

22.01

26.22

ug/l

1.34

1046

2920

COPD, hospital admissions 1, only main diagnosis

533

1744

2.66

89.89

1.8

22.86

24.67

ug/l

0.27

521

1697

Condition for Implicit Sepsis (Organ dysfunction codes)

883

3043

2.13

88.52

1.8

1.9

25.86

24.11

ug/l

0.30

849

3000

Early onset COPD

350

1107

3.24

87.52

1.8

1.9

25.16

24.36

ug/l

0.07

342

1079

Neuroendocrine tumor and carcinoma of pancreas

36.80

87.40

4.4

1.4

27.11

16.44

ug/l

1.28

Later onset COPD

457

1284

2.86

86.80

1.9

1.8

20.11

26.02

ug/l

1.92

449

1243

Asthma (only as main-diagnosis), excluding more controls

500

1109

2.70

80.63

1.8

2.0

20.86

22.86

ug/l

0.36

489

1095

Tramadol

703

2022

2.25

79.00

1.9

1.8

25.82

22.11

ug/l

0.72

687

1977

Asthma (only as main-diagnosis)

512

1194

2.60

77.20

1.8

2.0

20.72

22.96

ug/l

0.44

501

1172

Carcinoid syndrome

18.79

76.45

4.4

1.7

24.67

16.39

ug/l

1.06

Dyspnoea

886

3431

1.99

75.76

1.9

23.02

25.04

ug/l

0.51

863

3362

ILD medications

1047

3001

1.93

75.46

1.8

2.0

21.10

26.23

ug/l

2.21

1020

2946

Benign neoplasm: Colon, unspecified

195

456

4.32

75.10

1.7

1.3

26.06

20.00

ug/l

0.46

189

442

General symptoms and signs

1003

2570

1.97

74.90

2.0

1.9

24.10

25.41

ug/l

0.24

977

2523

Other heart diseases

426

1024

2.77

74.14

2.0

2.1

21.67

25.49

ug/l

0.61

415

1009

In situ neoplasms

222

552

3.87

73.25

1.9

1.3

21.50

26.25

ug/l

0.38

215

532

Implicit Sepsis

774

2955

2.06

72.06

1.8

1.9

26.12

24.55

ug/l

0.22

745

2906

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

348

790

3.03

71.70

1.7

1.3

22.68

24.09

ug/l

0.13

341

768

Enlarged lymph nodes

218

583

3.82

70.69

2.0

1.9

21.23

23.30

ug/l

0.23

212

574

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

22.36

70.49

2.4

1.3

19.92

15.09

ug/l

0.79

Inflammatory bowel disease treatment related agents

1046

3191

1.87

70.00

1.7

2.0

23.02

25.65

ug/l

0.66

1019

3131

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

128

226

5.79

69.25

2.1

1.2

20.16

19.57

ug/l

0.06

121

218

COPD/asthma related infections

940

2420

1.96

69.18

2.0

1.9

25.17

24.65

ug/l

0.06

919

2371

COPD/asthma/ILD related infections

940

2420

1.96

69.18

2.0

1.9

25.17

24.65

ug/l

0.06

919

2371

Asthma (mode)

533

1213

2.43

67.96

1.8

2.0

20.53

22.92

ug/l

0.50

525

1191

Codeine

768

2054

2.07

67.28

1.8

23.88

21.80

ug/l

0.24

753

2010

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

314

711

3.05

65.56

1.7

1.3

24.62

23.88

ug/l

0.05

308

689

Abnormalities of breathing

806

2442

1.97

63.59

1.9

23.09

25.08

ug/l

0.51

781

2398

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

127

242

5.34

63.03

2.0

1.2

24.34

21.93

ug/l

0.20

121

234

Pulmonary heart disease

364

1422

2.60

61.54

1.9

1.8

22.65

23.28

ug/l

0.08

359

1381

Renal tubulo-interstitial diseases

821

3339

1.90

61.16

1.9

22.69

24.88

ug/l

0.58

792

3281

Pulmonary embolism

364

1429

2.59

60.92

1.9

22.65

23.23

ug/l

0.08

359

1388

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

43.11

60.37

7.4

1.3

24.31

19.11

ug/l

—

Metabolic disorders

891

3013

1.85

58.59

2.0

1.9

27.18

24.03

ug/l

0.40

866

2958

Other disorders of fluid, electrolyte and acid-base balance

365

1414

2.53

57.81

2.1

1.8

25.05

23.23

ug/l

0.22

349

1377

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

172

349

4.03

57.29

1.7

1.3

18.24

28.23

ug/l

0.65

166

339

Pulmonary heart disease, diseases of pulmonary circulation

379

1578

2.44

55.95

1.9

1.8

22.38

23.43

ug/l

0.16

373

1529

Heart failure, not strict

791

2947

1.87

54.64

1.8

2.0

24.34

24.91

ug/l

0.08

766

2900

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

291

705

2.86

54.55

1.7

1.3

26.21

23.94

ug/l

0.15

285

683

Substance use, excluding alcohol

200

613

3.31

52.67

1.9

2.1

24.23

24.54

ug/l

0.03

195

605

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

284

701

2.82

51.80

1.7

1.3

26.47

24.01

ug/l

0.16

278

679

Septicaemia

443

1979

2.18

50.08

2.0

1.8

24.57

22.79

ug/l

0.38

426

1935

Other heart diseases, wide

763

2582

1.84

49.89

2.0

24.17

25.62

ug/l

0.24

744

2545

Other septicaemia

405

1789

2.25

49.74

2.0

1.8

24.46

23.09

ug/l

0.26

394

1747

Benign lipomatous neoplasm

170

494

3.47

48.61

1.9

1.3

20.72

24.19

ug/l

0.37

170

480

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

18.95

48.50

1.9

1.3

29.23

16.49

ug/l

1.01

Agranulocytosis

150

405

3.80

48.25

2.9

1.9

22.23

24.97

ug/l

0.31

150

398

Hypo-osmolality and hyponatraemia

220

750

2.98

48.24

2.0

1.8

27.74

23.47

ug/l

0.36

211

732

Diseases of arteries, arterioles and capillaries (FINNGEN)

278

723

2.72

47.58

1.9

39.08

26.95

ug/l

0.77

270

712

DVT of lower extremities and pulmonary embolism

453

2167

2.11

47.44

1.8

21.76

23.86

ug/l

0.43

445

2105

Explicit Sepsis

452

2098

2.09

45.91

2.0

1.9

24.39

23.03

ug/l

0.29

435

2055

Drug-induced neutropenia

113

262

4.46

44.90

3.0

1.8

23.25

23.44

ug/l

0.02

113

256

Asthma-related pneumonia

371

1691

2.22

44.24

1.9

18.64

24.16

ug/l

1.97

360

1640

Asthma-related pneumonia or sepsis

371

1696

2.21

43.91

1.9

18.64

24.14

ug/l

1.96

360

1644

Asthma, hospital admissions 3, pneumonia

371

1696

2.21

43.91

1.9

18.64

24.14

ug/l

1.96

360

1644

Benign neoplasm: Pancreas

12.88

43.83

2.6

1.3

12.35

15.39

ug/l

0.86

Malaise and fatigue

460

1892

2.04

43.17

1.8

1.9

26.04

24.95

ug/l

0.13

447

1850

Venous thromboembolism

541

2780

1.91

42.67

1.9

1.8

23.71

23.48

ug/l

0.04

531

2712

Asthma/COPD (KELA code 203)

760

3089

1.74

42.54

1.8

2.0

19.82

25.66

ug/l

2.03

746

3024

Diseases of the respiratory system

519

1290

2.03

42.44

1.9

2.0

21.07

27.14

ug/l

1.76

512

1263

Certain infectious and parasitic diseases

832

2417

1.73

42.25

2.1

1.9

25.51

25.01

ug/l

0.06

810

2379

Medical observation and evaluation for suspected diseases and conditions

623

1719

1.87

40.59

2.2

1.8

19.61

27.39

ug/l

3.88

603

1698

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

9.73

39.09

1.6

1.3

16.45

15.81

ug/l

0.11

Abnormal findings on examination of blood, without diagnosis

514

2575

1.89

39.04

2.1

1.9

22.44

24.75

ug/l

0.36

502

2523

Asthma-related infections

501

2628

1.89

38.69

1.9

19.43

25.33

ug/l

1.97

487

2560

Asthma, hospital admission 2, infections

501

2628

1.89

38.69

1.9

19.43

25.33

ug/l

1.97

487

2560

Bacterial Sepsis

470

2192

1.93

37.74

1.9

23.65

23.03

ug/l

0.12

446

2149

Symptoms and signs involving the urinary system

705

3216

1.71

37.16

2.0

1.9

23.64

24.80

ug/l

0.16

685

3150

Substance abuse, excluding more controls

531

2545

1.84

37.00

1.7

1.9

26.61

24.43

ug/l

0.28

516

2499

Implicit bacterial Sepsis

424

1987

1.98

36.93

1.9

24.28

23.29

ug/l

0.18

404

1944

Aplastic and other anaemias

462

2331

1.90

35.88

2.0

1.9

23.64

23.18

ug/l

0.05

444

2274

Other and unspecified anaemias

430

2179

1.93

35.18

2.0

1.8

23.61

23.31

ug/l

0.03

412

2124

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

127

378

3.40

35.16

1.7

1.3

19.41

19.84

ug/l

0.05

122

364

Benign neoplasm: Bronchus and lung

15.75

35.11

1.3

45.34

15.44

ug/l

0.42

Other anaemias

432

2199

1.92

34.58

2.0

1.9

23.57

23.24

ug/l

0.03

414

2144

Mental and behavioural disorders due to psychoactive substance use

547

2924

1.78

34.54

1.7

1.9

26.36

24.60

ug/l

0.22

532

2873

Heart failure and antihypertensive medication

282

824

2.29

33.36

1.6

2.1

22.48

24.76

ug/l

0.35

270

811

Substance abuse

531

2885

1.77

33.22

1.7

1.9

26.61

24.47

ug/l

0.27

516

2835

Diseases of oesophagus, stomach and duodenum

867

3343

1.58

32.74

1.9

24.47

24.95

ug/l

0.05

842

3284

Malignant neoplasm of other and ill-defined digestive organs

12.97

32.46

1.8

1.5

19.78

15.95

ug/l

0.51

Complications of surgical and medical care, not elsewhere classified

798

3599

1.60

32.38

1.9

22.79

25.06

ug/l

0.52

778

3528

Pain in throat and chest

658

2393

1.69

32.15

1.9

28.50

24.99

ug/l

0.34

644

2349

Malignant neoplasm of adrenal gland

24.11

31.78

9.6

1.9

27.73

15.28

ug/l

1.26

Leiomyoma of uterus

161

301

3.03

31.56

1.7

1.4

18.95

30.55

ug/l

0.64

156

293

Codeine or tramadol medication

919

3290

1.55

31.48

1.8

1.9

25.16

24.54

ug/l

0.07

901

3221

Bleeding

741

3359

1.61

31.38

1.9

21.29

25.55

ug/l

1.10

719

3293

Dental caries

256

1154

2.22

30.90

2.6

1.9

30.25

23.18

ug/l

0.73

251

1128

COPD-related respiratory insufficiency

152

545

2.85

30.86

1.6

1.9

24.28

26.25

ug/l

0.15

145

530

Persons encountering health services in other circumstances, wide

982

3351

1.53

30.70

2.0

1.9

27.14

24.50

ug/l

0.35

967

3276

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

314

958

2.09

29.86

1.8

2.0

22.46

25.53

ug/l

0.39

308

944

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

7.03

29.71

1.6

1.3

18.50

14.95

ug/l

1.49

Diseases of arteries, arterioles and capillaries

643

2934

1.65

29.62

1.7

1.9

31.84

23.00

ug/l

1.58

623

2873

General examination and investigation of persons without complaint and reported diagnosis

558

1714

1.74

29.56

1.8

31.36

27.21

ug/l

0.33

540

1694

Atrial fibrillation and flutter

280

851

2.17

29.22

1.9

22.67

25.82

ug/l

0.29

273

838

Heart failure,strict

544

2308

1.72

28.96

1.6

1.9

20.99

23.73

ug/l

0.82

519

2267

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

9.50

28.41

1.5

1.3

15.90

15.67

ug/l

0.04

Chronic pancreatitis

157

598

2.68

28.40

2.2

1.9

16.07

25.41

ug/l

3.11

152

590

Chronic periodontitis, complicated

124

417

3.04

28.35

2.2

1.9

23.37

24.16

ug/l

0.05

119

412

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

762

3319

1.57

28.32

1.9

2.0

23.26

25.35

ug/l

0.40

741

3260

Other diseases of the respiratory system

232

1055

2.23

28.27

1.6

1.9

27.79

23.13

ug/l

0.36

222

1029

Other respiratory disorders and diseases

232

1055

2.23

28.27

1.6

1.9

27.79

23.13

ug/l

0.36

222

1029

Parasetamol

590

1783

1.70

28.24

2.1

1.9

21.77

27.27

ug/l

1.59

577

1752

Benzodiazepine use

789

3638

1.55

28.18

1.9

28.16

23.86

ug/l

0.54

772

3565

Oedema, not elsewhere classified

274

1325

2.08

27.97

1.8

21.77

24.84

ug/l

0.40

266

1292

Benign neoplasm: Ascending colon

229

3.76

27.50

1.8

1.3

22.19

18.75

ug/l

0.30

222

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

12.82

27.40

2.0

1.3

18.04

16.80

ug/l

0.15

Haemorrhage from respiratory passages

344

1701

1.89

26.68

1.8

1.9

18.18

23.83

ug/l

2.37

336

1665

Cardiovascular diseases (excluding rheumatic etc)

359

1090

1.91

26.16

2.0

2.1

22.36

25.37

ug/l

0.42

351

1075

Cardiac arrhythmias

416

1539

1.79

25.75

2.0

24.34

25.46

ug/l

0.11

406

1518

Diseases of pulp and periapical tissues

319

1687

1.91

25.65

2.0

1.9

23.72

24.83

ug/l

0.11

314

1651

Pain, not elsewhere classified

213

978

2.20

25.28

2.1

2.0

25.26

22.32

ug/l

0.33

207

958

Symptoms and signs involving the digestive system and abdomen

828

2742

1.52

25.24

2.1

1.9

21.51

25.92

ug/l

1.27

808

2690

Asthma (diagnoses ohter than nonallergic)

659

3653

1.55

24.33

1.8

1.9

19.33

25.14

ug/l

2.80

646

3574

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

221

3.62

24.20

1.8

1.2

20.61

19.78

ug/l

0.07

213

Chronic periodontitis

172

740

2.36

24.02

2.2

1.9

25.00

23.55

ug/l

0.12

165

724

Parodontitis or operation codes

724

3537

1.51

23.51

2.0

1.9

29.59

23.61

ug/l

0.75

707

3466

Parodontitis

723

3538

1.51

23.39

2.0

1.9

29.61

23.61

ug/l

0.76

706

3467

Retention of urine

368

1760

1.79

23.28

2.0

1.8

24.20

24.42

ug/l

0.02

357

1720

Chronic periodontitis, including avohilmo

720

3538

1.51

23.26

2.0

1.9

29.69

23.60

ug/l

0.77

703

3467

Benign neoplasm: Skin of eyelid, including canthus

239

3.42

22.91

1.9

1.2

22.30

17.98

ug/l

0.54

232

Abdominal and pelvic pain

811

2741

1.49

22.88

2.0

1.9

21.97

25.92

ug/l

1.01

790

2689

Atrial fibrillation and flutter with reimbursement

241

748

2.08

22.85

1.7

1.9

17.71

26.62

ug/l

1.63

236

737

Disorders of gallbladder, biliary tract and pancreas

791

3450

1.48

22.75

1.9

24.02

24.86

ug/l

0.11

768

3387

Peripheral artery disease

449

2196

1.66

21.74

1.7

1.8

36.37

22.35

ug/l

1.96

433

2142

Atherosclerosis, excluding cerebral and coronary sclerosis

432

2082

1.67

21.53

1.7

1.8

37.43

22.00

ug/l

2.16

417

2031

Infections, IBD-co-morbidities

162

504

2.37

21.47

1.9

2.1

19.10

24.38

ug/l

1.02

155

491

Intestinal stricture

289

1573

1.86

21.39

2.3

1.9

19.51

22.92

ug/l

0.90

284

1526

Heart failure, strict

569

2634

1.57

21.35

1.6

1.9

21.11

24.67

ug/l

1.21

544

2586

Acute tubulo-interstitial nephritis

487

2702

1.61

21.22

1.9

19.39

24.11

ug/l

2.10

476

2649

Use of hypnotics and sedatives

835

3341

1.45

21.05

1.9

26.96

23.56

ug/l

0.55

813

3283

Symptoms and signs involving the circulatory and respiratory systems

728

2445

1.50

20.92

2.0

1.9

24.48

25.06

ug/l

0.08

712

2401

Complications of procedures, not elsewhere classified

614

3506

1.52

20.89

1.9

22.99

24.98

ug/l

0.38

602

3435

All-cause Heart Failure

558

2610

1.55

20.14

1.6

1.9

21.14

24.60

ug/l

1.14

534

2563

Other diseases of intestines

775

3102

1.46

20.08

1.9

2.0

24.16

24.46

ug/l

0.04

757

3044

Disorders of lipoprotein metabolism and other lipidaemias

680

2885

1.49

19.86

1.9

1.8

29.49

24.00

ug/l

0.62

661

2831

Other diseases of pericardium

184

3.64

19.82

2.0

17.26

32.13

ug/l

1.35

184

Renal failure

423

2386

1.63

19.71

1.7

1.9

26.17

23.46

ug/l

0.50

400

2332

Disorders of other endocrine glands

311

1744

1.76

19.66

2.6

1.9

24.23

23.10

ug/l

0.15

306

1700

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

9.10

19.49

1.5

1.2

32.55

15.39

ug/l

0.97

Bacterial pneumoniae

330

1695

1.73

19.30

1.7

1.8

24.72

22.94

ug/l

0.21

322

1648

Other disorders of teeth and supporting structures

201

1007

2.02

19.15

2.3

1.9

17.50

22.65

ug/l

2.14

194

984

Benign neoplasms

735

2824

1.46

18.99

2.0

1.9

23.69

23.89

ug/l

0.03

723

2765

Hypertensive diseases (excluding secondary)

308

1005

1.79

18.54

2.0

2.1

21.88

25.21

ug/l

0.30

301

991

Symptoms and signs concerning food and fluid intake

372

2.70

18.47

1.6

1.9

30.20

23.32

ug/l

0.23

367

Complications of medical and surgical care

557

3530

1.50

18.40

2.0

1.9

25.36

24.17

ug/l

0.17

543

3456

Hypertension, essential

560

2104

1.52

18.09

2.0

1.9

24.22

24.50

ug/l

0.03

547

2066

Persons encountering health services for other counselling and medical advice, not elsewhere classified

822

3327

1.41

18.06

2.1

1.9

23.49

24.42

ug/l

0.15

808

3253

Other functional intestinal disorders

363

2102

1.65

18.05

1.8

2.0

28.10

23.15

ug/l

0.32

354

2052

Type 2 diabetes, wide definition

658

2946

1.46

17.77

1.9

1.8

27.10

24.33

ug/l

0.37

633

2891

Constipation

697

3478

1.44

17.74

1.8

1.9

21.75

25.21

ug/l

1.09

675

3412

Benign neoplasm: Bronchus and lung

6.20

17.67

1.3

1.7

45.34

16.33

ug/l

0.41

Examination and observation for other reasons

441

1700

1.58

17.10

2.1

1.8

24.46

27.28

ug/l

0.32

426

1680

Cardiovascular diseases

304

945

1.76

17.09

2.1

21.98

25.77

ug/l

0.51

297

934

Benign neoplasm of colon, rectum, anus and anal canal

535

3255

1.49

16.83

1.6

1.9

24.49

24.79

ug/l

0.03

523

3186

Abscess of lung

6.05

16.83

1.3

2.0

11.69

16.88

ug/l

2.74

Acute renal failure

208

1105

1.90

16.80

1.8

29.29

23.23

ug/l

0.85

195

1080

Alcohol use disorder, Swedish definition

469

2864

1.53

16.66

1.7

1.9

25.96

24.79

ug/l

0.13

454

2816

Unspecified haematuria

396

2151

1.59

16.44

2.0

1.9

26.47

24.31

ug/l

0.18

383

2107

Viral Sepsis

166

822

2.04

16.42

1.8

1.9

22.63

22.67

ug/l

0.00

159

803

ILD, hospital admission 2, with pulmonary infections

355

2.63

16.40

1.7

1.8

26.92

25.79

ug/l

0.05

346

501

3000

1.50

16.39

1.7

1.9

25.73

24.76

ug/l

0.11

486

2950

Parodontitis and operation codes

652

3557

1.43

16.23

1.9

28.20

24.01

ug/l

0.46

637

3487

Implicit viral Sepsis

165

821

2.03

16.12

1.8

1.9

22.70

22.68

ug/l

0.00

158

802

Bacterial pneumonia, not elsewhere classified

305

1617

1.68

15.97

1.7

1.8

22.93

23.11

ug/l

0.02

298

1572

295

1746

1.68

15.94

2.1

2.0

20.06

24.20

ug/l

0.76

284

1706

Diagnoses used for exclusion with ILD

230

1288

1.80

15.68

1.6

1.9

19.58

23.89

ug/l

0.96

221

1260

Iron deficiency anaemia

320

1947

1.64

15.47

1.6

1.9

21.35

22.97

ug/l

0.17

299

1902

Fitting and adjustment of other devices

275

1508

1.71

15.45

1.5

1.7

20.23

22.12

ug/l

0.33

264

1464

Other and unspecified iron deficiency

253

1465

1.74

15.33

1.7

1.9

16.83

23.17

ug/l

3.84

239

1429

Other CVD (FINNGEN)

108

357

2.41

15.32

1.8

26.84

22.19

ug/l

0.23

101

349

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

7.09

15.29

1.5

1.2

18.77

15.42

ug/l

0.76

Erysipelas

425

2545

1.53

15.26

1.6

1.8

22.32

24.31

ug/l

0.27

411

2495

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

181

3.23

15.14

2.1

1.3

21.80

17.68

ug/l

0.32

176

Hard cardiovascular diseases

650

2950

1.42

15.09

1.9

22.76

25.75

ug/l

0.64

636

2891

Heart failure and bmi 25plus

318

1335

1.65

15.05

1.6

2.0

20.16

26.65

ug/l

1.95

306

1310

477

2956

1.49

15.01

1.6

1.9

25.17

24.70

ug/l

0.05

462

2906

Pure hypercholesterolaemia

589

2770

1.43

14.50

1.9

28.36

23.70

ug/l

0.44

573

2718

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

11.71

14.45

2.1

1.3

14.17

16.40

ug/l

0.58

Fall on same level

831

3439

1.35

14.20

1.8

2.0

22.55

25.32

ug/l

0.70

808

3383

ILD, hospital admissions 3, with pneumonia sepsis

311

2.61

14.13

1.7

28.92

27.43

ug/l

0.06

304

Lung diseases due to external agents

138

678

2.06

14.06

1.7

1.8

16.70

24.58

ug/l

2.61

131

666

Adjustment and management of implanted device

157

810

1.96

13.92

2.0

1.8

21.02

22.46

ug/l

0.21

152

781

Non-ischemic cardiomyopathy

279

1393

1.66

13.75

1.7

1.9

22.27

24.41

ug/l

0.33

269

1360

Hypertensive diseases

545

2140

1.45

13.73

2.1

2.0

24.67

24.48

ug/l

0.02

534

2102

Hypertension

544

2137

1.44

13.66

2.1

2.0

24.69

24.48

ug/l

0.02

533

2099

Nutritional anaemias

370

2359

1.53

13.58

1.6

1.9

23.25

24.24

ug/l

0.09

349

2304

Symptoms and signs involving cognition, perception, emotional state and behaviour

702

3613

1.37

13.27

1.7

2.0

20.55

25.50

ug/l

1.37

681

3543

Parodontitis or/and operation codes

415

1640

1.51

13.13

1.9

1.8

26.36

20.78

ug/l

1.01

402

1612

Psychiatric diseases

826

3090

1.34

13.13

1.9

2.0

25.05

24.76

ug/l

0.03

805

3029

ILD, hospital admissions

146

751

1.97

13.13

1.6

1.9

23.09

24.14

ug/l

0.08

141

733

Malignant neoplasm of urinary organs

103

468

2.23

12.92

2.0

1.9

20.62

24.12

ug/l

0.43

460

Mental and behavioural disorders due to alcohol

407

2679

1.49

12.88

1.6

1.9

26.46

24.50

ug/l

0.20

395

2631

Endocrine, nutritional and metabolic diseases

537

1910

1.43

12.75

2.1

2.0

24.77

24.24

ug/l

0.07

529

1878

Diabetes mellitus

721

3181

1.36

12.72

1.9

24.75

24.27

ug/l

0.06

701

3120

Interstitial lung disease

147

769

1.93

12.60

1.6

1.9

23.06

23.84

ug/l

0.06

142

751

Interstitial lung disease endpoints

147

769

1.93

12.60

1.6

1.9

23.06

23.84

ug/l

0.06

142

751

Type 2 diabetes

709

3112

1.36

12.52

1.9

24.50

24.32

ug/l

0.02

690

3052

Bacterial pneumonia (organism specified)

358

2159

1.52

12.47

1.7

1.9

24.52

23.86

ug/l

0.07

350

2098

Other interstitial pulmonary diseases

147

772

1.93

12.46

1.6

1.9

23.06

24.60

ug/l

0.12

142

754

Diabetes, varying definitions

718

3181

1.35

12.45

1.9

24.51

24.29

ug/l

0.02

699

3119

Valvular heart disease excluding rheumatic fever

396

1945

1.50

12.40

1.7

2.0

23.24

24.81

ug/l

0.19

380

1913

Any mental disorder

837

3167

1.33

12.35

1.8

2.0

25.77

24.53

ug/l

0.17

816

3103

Benign neoplasm: Colon

445

3026

1.45

12.35

1.7

1.9

26.40

24.04

ug/l

0.23

436

2957

Non-rheumatic valve diseases

393

1933

1.49

12.17

1.7

1.9

23.21

24.85

ug/l

0.20

377

1902

Hernia

667

3355

1.35

11.85

1.8

1.9

27.13

24.02

ug/l

0.33

649

3288

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

12.63

11.83

1.9

1.5

18.01

18.33

ug/l

—

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

12.38

11.79

1.8

1.4

14.69

17.30

ug/l

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

7.88

11.49

1.1

1.3

13.69

15.86

ug/l

0.31

Paroxysmal tachycardia

150

683

1.87

11.41

1.8

1.9

17.89

25.38

ug/l

1.19

145

672

Colectomy operation

149

811

1.86

11.34

2.4

1.9

16.53

23.55

ug/l

2.55

143

794

Other abnormalities of plasma proteins

5.09

11.32

1.5

12.90

16.72

ug/l

1.45

STROKE

438

2122

1.44

11.23

1.9

22.53

24.35

ug/l

0.24

428

2088

Codes for special purposes

283

1832

1.55

11.13

2.0

19.93

23.56

ug/l

0.99

276

1785

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

685

3141

1.34

11.04

2.0

1.9

23.88

24.38

ug/l

0.06

664

3080

Mental and behavioural disorders due to alcohol, excluding acute intoxication

360

2454

1.47

11.03

1.6

1.9

27.35

24.18

ug/l

0.32

348

2409

Polycystic ovarian syndrome, consortium definition

314

1234

1.54

11.01

1.9

19.46

24.88

ug/l

1.15

299

1211

Provisional assignment of new diseases of uncertain etiology

282

1830

1.55

10.98

2.0

19.95

23.57

ug/l

0.98

275

1783

Diverticular disease of intestine

568

2767

1.37

10.87

1.8

1.9

21.08

24.37

ug/l

0.60

552

2714

Infections of the skin and subcutaneous tissue

385

2656

1.45

10.87

1.8

2.0

19.01

24.13

ug/l

2.63

376

2594

Malignant neoplasm of thymus

11.08

10.63

3.2

1.7

27.97

18.08

ug/l

0.44

Paralytic ileus and intestinal obstruction

213

1307

1.64

10.57

2.1

1.9

20.62

22.42

ug/l

0.30

208

1271

Diabetes medication

714

3302

1.32

10.51

2.0

1.9

24.53

24.09

ug/l

0.05

692

3238

Asthma, including avohilmo

814

3661

1.29

10.47

1.9

20.91

25.71

ug/l

1.57

801

3584

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

5.52

10.44

2.0

1.3

17.87

15.61

ug/l

0.27

Other symptoms and signs involving the digestive system and abdomen

108

544

2.00

10.37

2.4

1.9

21.50

22.61

ug/l

0.16

102

534

Spondylopathies

609

2764

1.34

10.20

1.8

1.9

31.32

23.92

ug/l

0.76

593

2708

Alcohol use disorder, ICD-based

329

2243

1.47

10.18

1.6

1.9

28.32

24.33

ug/l

0.38

318

2198

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

703

3499

1.31

10.16

1.9

21.39

25.62

ug/l

1.49

689

3429

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

18.45

10.12

2.9

1.4

25.96

19.25

ug/l

—

Gastro-oesophageal reflux disease

487

3146

1.38

10.12

1.7

1.9

22.28

24.79

ug/l

0.35

473

3090

Other acute lower respiratory infections

370

2462

1.44

10.09

2.0

1.9

29.98

23.23

ug/l

0.46

358

2397

796

3256

1.29

10.04

2.0

1.9

25.95

25.04

ug/l

0.09

779

3188

Asthma, hospital admissions , main diagnosis only

541

3597

1.35

10.03

1.8

1.9

20.70

24.77

ug/l

1.25

529

3517

Non-invasive ventilation

146

771

1.79

9.92

1.7

2.1

31.24

24.06

ug/l

0.36

136

761

Type 2 diabetes, definitions combined

677

3081

1.31

9.82

1.9

21.93

24.35

ug/l

0.46

660

3022

Dysphagia

191

1164

1.65

9.80

1.9

1.8

26.27

23.22

ug/l

0.18

185

1130

Chronic kidney disease

256

1664

1.54

9.80

1.5

1.9

25.69

23.36

ug/l

0.28

239

1624

Gastrointestinal diseases

358

1224

1.47

9.76

2.1

1.9

24.21

26.62

ug/l

0.25

353

1210

Diabetes, insulin treatment (Kela reimbursement)

717

3378

1.30

9.72

2.0

1.9

25.23

24.24

ug/l

0.12

694

3313

Myocardial infarction

452

2344

1.39

9.72

1.7

1.9

24.54

ug/l

0.00

438

2296

Type 2 diabetes, definitions combined, including avohilmo

677

3066

1.31

9.60

1.9

22.02

24.43

ug/l

0.46

660

3007

Malignant neoplasm of breast, HER2-negative

255

1216

1.55

9.55

1.7

1.8

18.11

25.41

ug/l

2.06

248

1189

Syncope and collapse

318

1927

1.47

9.54

1.7

1.8

18.18

24.98

ug/l

3.48

305

1887

Weight loss

367

2.18

9.49

1.5

2.1

31.67

23.28

ug/l

0.22

362

Other respiratory diseases principally affecting the interstitium

158

925

1.72

9.48

1.5

1.8

22.50

23.36

ug/l

0.07

153

905

Neuroendocrine tumor and carcinoma of stomach

9.19

9.47

1.7

1.4

11.81

15.66

ug/l

1.64

Type 2 diabetes, strict (exclude DM1)

679

3110

1.31

9.46

1.9

21.91

24.39

ug/l

0.48

662

3050

Wilms' tumor, excluding all cancers (controls excluding all cancers)

9.02

9.43

6.0

1.4

29.23

16.95

ug/l

0.69

Dorsalgia

687

2853

1.31

9.43

1.9

29.31

23.96

ug/l

0.58

677

2795

Gastroduodenal ulcer

227

1454

1.57

9.39

1.9

31.49

25.08

ug/l

0.24

216

1419

Ischemic heart diseases

617

2934

1.32

9.37

1.9

24.35

24.76

ug/l

0.05

601

2879

Polyarthropathies

506

2490

1.36

9.36

1.8

2.0

22.98

26.15

ug/l

0.72

494

2436

Presence of cardiac and vascular implants and grafts

411

2230

1.40

9.35

1.6

1.9

25.19

25.07

ug/l

0.01

393

2184

Colorectal cancer

206

1305

1.59

9.08

1.9

1.8

18.12

24.07

ug/l

2.41

198

1270

Malignant neoplasm of breast

257

1219

1.53

9.07

1.7

1.8

18.08

25.37

ug/l

2.07

250

1192

Dermatitis

416

3022

1.38

9.07

1.8

1.9

30.52

23.19

ug/l

0.58

405

2962

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

427

3104

1.38

9.05

2.0

1.8

27.08

24.06

ug/l

0.41

416

3038

Persons encountering health services for examination and investigation

471

1719

1.38

9.04

2.1

1.8

19.99

27.39

ug/l

3.18

466

1698

Other antidepressants

750

3055

1.28

8.95

1.8

1.9

23.28

23.57

ug/l

0.04

733

2996

Glucagon-like peptide-1 (GLP-1) analogues

456

2767

1.36

8.84

1.9

22.17

23.95

ug/l

0.37

444

2708

Pneumonitis due to solids and liquids

328

2.19

8.69

1.6

1.7

15.83

26.27

ug/l

1.78

321

Hyperlipidaemia, other/unspecified

320

2121

1.44

8.63

1.8

26.25

23.39

ug/l

0.25

314

2076

Benign neoplasm: Other and unspecified parts of mouth

4.60

8.61

1.8

1.2

77.26

15.54

ug/l

0.71

Acute bronchitis

282

1894

1.46

8.55

2.0

1.9

34.13

23.13

ug/l

0.62

273

1838

Cerebrovascular diseases

588

3233

1.31

8.51

1.8

1.9

23.55

25.27

ug/l

0.22

574

3166

Cushing syndrome

5.33

8.48

4.9

1.6

52.71

17.31

ug/l

1.08

Fracture of rib(s), sternum and thoracic spine

236

1569

1.51

8.39

1.6

1.9

18.88

23.74

ug/l

1.54

231

1526

Unspecific neurodegenerative disorder

157

1753

0.61

8.31

1.4

1.8

16.10

23.66

ug/l

3.92

152

1703

Injuries to the head

733

3772

1.27

8.30

1.8

2.0

22.61

25.21

ug/l

0.52

711

3703

Other special examinations and investigations of persons without complaint or reported diagnosis

461

1719

1.36

8.27

2.1

1.8

21.31

27.39

ug/l

2.08

453

1698

Dementia

171

1871

0.63

8.24

1.5

1.8

17.45

24.47

ug/l

3.18

164

1819

Adrenomedullary hyperfunction

9.97

8.22

1.8

12.72

15.52

ug/l

—

Insulin medication

442

2811

1.35

8.19

2.0

1.9

28.93

23.46

ug/l

0.67

427

2752

Diarrhoea and gastroenteritis of presumed infectious origin

434

2928

1.35

8.18

2.0

1.9

20.01

23.66

ug/l

1.38

422

2859

Cough

273

1800

1.46

8.17

1.8

1.9

24.62

24.20

ug/l

0.03

263

1764

Hypoplasia of dental enamel, including avohilmo

5.80

8.10

9.4

3.4

30.14

23.74

ug/l

0.44

Major coronary heart disease event excluding revascularizations

546

2886

1.31

8.03

1.7

1.9

23.83

24.01

ug/l

0.02

527

2827

Other (not insulin) diabetes medications

681

3226

1.28

8.00

1.9

24.44

24.18

ug/l

0.03

661

3164

Other arrhythmias

413

2332

1.36

7.96

1.9

22.20

25.55

ug/l

0.57

403

2297

Benign neoplasm: Duodenum

4.69

7.90

1.8

1.3

30.48

15.73

ug/l

0.66

Diseases of the digestive system

343

2469

1.39

7.89

1.8

1.9

19.25

23.67

ug/l

0.95

334

2405

Certain disorders involving the immune mechanism

135

800

1.70

7.82

1.6

2.1

21.48

24.61

ug/l

0.35

129

788

Ischaemic heart disease, wide definition

602

2935

1.29

7.67

1.9

24.39

24.74

ug/l

0.04

585

2880

Syndrome of inappropriate secretion of antidiuretic hormone

7.76

7.64

1.8

28.27

18.29

ug/l

0.34

Other and unspecified dermatitis

334

2413

1.39

7.63

1.8

1.9

32.46

23.20

ug/l

0.61

327

2360

Alcohol dependence

216

1440

1.51

7.63

1.6

2.0

29.67

24.06

ug/l

0.47

210

1407

Other bacterial intestinal infections

130

768

1.70

7.63

2.1

1.9

18.36

23.45

ug/l

1.34

123

750

Chronic gastritis

216

1440

1.51

7.63

2.0

1.8

21.39

23.32

ug/l

0.28

210

1405

Bacterial intestinal infections, IBD co-morbidities

130

769

1.70

7.59

2.1

2.0

18.38

23.73

ug/l

1.43

123

754

Mycoses

181

1163

1.56

7.57

1.7

2.0

17.65

24.01

ug/l

2.77

176

1142

Duodenal ulcer

106

593

1.81

7.56

1.6

1.9

43.60

25.18

ug/l

0.35

101

582

Low back pain

478

2808

1.31

7.37

1.9

28.41

23.75

ug/l

0.35

466

2752

Injuries to the thorax

326

2361

1.39

7.36

1.6

1.9

19.44

23.87

ug/l

1.71

320

2295

Coronary atherosclerosis

545

2721

1.30

7.35

1.8

1.9

26.69

24.67

ug/l

0.23

526

2667

Other soft tissue disorders, not elsewhere classified

612

2968

1.28

7.32

1.8

2.0

23.72

25.36

ug/l

0.22

597

2906

Diseases of oral cavity, salivary glands and jaws

661

2677

1.27

7.30

2.1

1.9

24.06

24.56

ug/l

0.07

647

2621

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

5.50

7.28

2.1

1.3

21.71

15.30

ug/l

0.99

Exclusions for E4_PCOS_CONSORTIUM

342

1549

1.39

7.28

2.3

1.9

22.93

24.63

ug/l

0.26

333

1521

Other diseases of the digestive system

255

1777

1.44

7.21

1.8

1.9

19.86

23.73

ug/l

0.53

246

1733

Myeloid leukaemia

4.54

7.20

1.2

17.59

14.44

ug/l

0.33

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

391

2923

1.34

7.19

2.0

1.8

26.59

24.10

ug/l

0.31

380

2856

Hydrocephalus in other diseases

8.06

7.19

3.6

1.7

22.90

18.11

ug/l

—

Secondary hypertension

265

2.19

7.17

2.2

1.7

16.72

22.69

ug/l

1.36

260

Major coronary heart disease event

573

2997

1.28

7.07

1.8

1.9

23.89

24.95

ug/l

0.16

554

2935

Disorders of lens

543

2667

1.29

7.01

1.9

19.96

26.99

ug/l

2.69

524

2625

Carcinoma in situ of middle ear and respiratory system

14.61

6.99

1.5

1.4

14.38

11.43

ug/l

—

Nephropathy related operations

101

572

1.78

6.95

1.8

2.2

29.06

24.15

ug/l

0.39

566

Pain in limb

519

2919

1.29

6.90

1.9

2.0

24.43

25.41

ug/l

0.11

506

2857

Benign neoplasm of other and unspecified intrathoracic organs

6.63

6.81

1.8

1.3

23.49

15.98

ug/l

0.28

Iron deficiency anaemia secondary to blood loss (chronic)

112

658

1.71

6.77

1.5

1.9

30.11

23.98

ug/l

0.23

102

645

Medicines for HER+ breast cancer

182

1170

1.52

6.76

1.6

1.8

18.10

24.92

ug/l

1.74

175

1145

Bronchitis

700

3704

1.24

6.73

2.0

1.9

26.76

24.22

ug/l

0.25

683

3629

Dizziness and giddiness

515

3271

1.28

6.66

1.7

1.9

22.07

25.22

ug/l

0.50

501

3204

Biguanides

663

3278

1.25

6.65

1.9

26.23

24.16

ug/l

0.25

645

3213

Osteoporosis

164

1013

1.55

6.64

2.0

1.8

19.90

23.14

ug/l

0.67

157

986

Nonischemic cardiomyopathy

225

2.25

6.63

1.7

1.9

17.40

25.82

ug/l

0.83

225

Intestinal infectious diseases

597

3702

1.26

6.59

2.0

1.9

20.60

25.57

ug/l

2.19

582

3626

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

4.20

6.56

1.1

1.3

21.54

14.80

ug/l

0.49

Personality disorders, excluding more controls

118

710

1.67

6.51

1.5

2.0

21.10

21.97

ug/l

0.13

113

700

Eosinophilic disease (BM)

4.92

6.48

1.1

1.4

37.91

21.03

ug/l

0.35

Dementia, including avohilmo

197

1984

0.68

6.48

1.4

1.8

17.15

24.61

ug/l

3.92

189

1930

Dialysis, with operation codes

104

607

1.73

6.47

1.7

2.2

35.34

24.43

ug/l

0.83

601

Osteopathies and chondropathies

353

2511

1.34

6.39

2.1

1.9

26.67

22.85

ug/l

0.22

339

2450

Any dementia

148

1605

0.65

6.37

1.5

1.8

18.47

23.71

ug/l

1.72

142

1557

Malignant neoplasm of peripheral nerves and autonomic nervous system, excluding all cancers (controls excluding all cancers)

19.21

6.36

5.7

1.4

19.29

12.18

ug/l

—

GI-bleeding

251

1788

1.41

6.34

1.8

1.9

19.53

23.93

ug/l

0.63

243

1743

L02BG Aromatase inhibitors

153

988

1.56

6.34

1.6

1.8

18.41

25.81

ug/l

1.55

148

968

Benign neoplasm: Tonsil

6.81

6.34

2.1

1.3

12.15

15.96

ug/l

—

Peripheral arterial reconstruction

149

958

1.57

6.33

1.7

1.8

48.07

21.48

ug/l

1.66

143

933

Benign neoplasm: other/unspecified salivary gland

4.26

6.30

1.7

1.3

37.01

15.08

ug/l

1.16

Acute pancreatitis

151

975

1.56

6.28

2.3

1.9

19.87

25.31

ug/l

0.86

146

956

Benign neoplasm: Lip

4.73

6.23

2.6

1.3

13.91

14.65

ug/l

0.13

Diseases of the skin and subcutaneous tissue

719

2930

1.23

6.22

1.8

2.0

22.99

24.87

ug/l

0.42

697

2874

Use of disulfiram, acamprosate or naltrexone

298

2.03

6.19

1.7

1.9

34.60

24.02

ug/l

0.38

293

Lower back pain or/and sciatica

666

3748

1.23

6.19

1.9

29.75

23.62

ug/l

0.68

653

3670

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

5.94

6.14

1.9

1.3

17.45

15.94

ug/l

0.14

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

12.93

6.13

3.2

1.6

14.57

12.83

ug/l

—

Appendectomy

365

2667

1.32

6.13

2.0

1.9

19.02

24.67

ug/l

2.62

356

2611

Disorders of magnesium metabolism

5.45

6.07

2.4

1.5

16.57

17.33

ug/l

0.05

Senile cataract

514

2513

1.27

6.07

2.0

1.9

21.43

26.89

ug/l

1.49

497

2473

Intracranial trauma

355

1999

1.33

6.04

1.8

2.0

28.56

26.97

ug/l

0.07

342

1967

Acute pancreatitis (for exclusion)

151

985

1.54

6.02

2.3

1.9

19.87

24.55

ug/l

0.70

146

966

Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

16.03

6.00

2.7

1.7

14.51

23.53

ug/l

—

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

4.90

6.00

1.8

1.3

21.76

15.18

ug/l

0.35

Tic and related disorders

6.35

5.97

3.0

6.8

15.89

23.54

ug/l

—

Pain (limb, back, neck, head abdominally)

540

2140

1.27

5.96

2.1

1.9

21.14

24.81

ug/l

1.25

530

2098

Insulin, intermediate and long-acting

402

3049

1.30

5.91

2.0

1.9

28.88

23.41

ug/l

0.60

388

2981

Acute alcohol intoxication

190

1306

1.46

5.88

1.6

2.0

29.19

23.21

ug/l

0.44

185

1277

Other abnormal uterine and vaginal bleeding

127

564

1.61

5.86

1.7

1.8

18.51

27.05

ug/l

1.01

119

546

Malignant neoplasm of breast, HER-positive

171

1136

1.49

5.83

1.7

1.8

18.25

25.17

ug/l

1.70

165

1112

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

11.44

5.83

2.1

1.4

13.55

12.34

ug/l

—

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

11.43

5.83

2.3

1.3

22.91

13.69

ug/l

—

Malignant neoplasm of cervix uteri

5.09

5.76

2.4

1.5

13.36

29.24

ug/l

0.99

Open wound of head

365

2758

1.31

5.72

1.7

2.0

21.12

24.55

ug/l

0.75

356

2699

Cardiomyopathy

141

918

1.55

5.70

1.8

1.9

20.29

24.63

ug/l

0.77

136

901

Non-selective monoamine reuptake inhibitors

259

1835

1.37

5.66

1.9

32.20

21.41

ug/l

1.09

249

1794

Drug-induced adrenocortical insufficiency

3.61

5.64

1.3

1.8

12.53

17.08

ug/l

2.00

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

3.85

5.55

2.2

1.3

21.60

14.94

ug/l

0.50

Benign neoplasm: Liver

5.30

5.53

1.1

1.3

16.15

15.77

ug/l

0.03

Other dorsopathies, not elsewhere classified

662

2857

1.22

5.49

1.9

21.95

23.95

ug/l

0.34

651

2799

Coagulation defects, purpura and other haemorrhagic conditions

119

753

1.59

5.46

2.0

22.13

23.93

ug/l

0.18

114

741

Inguinal hernia

459

2445

1.27

5.45

1.9

25.20

24.80

ug/l

0.05

447

2395

Allergic asthma (mode)

426

1.78

5.43

1.6

2.1

21.12

24.85

ug/l

0.33

417

Other disorders of urethra and urinary system

447

2644

1.27

5.43

2.0

1.8

19.01

25.40

ug/l

3.24

434

2589

Insulin, combination of fast acting with intermediate-acting or long-acting

442

3226

1.27

5.39

2.0

1.9

28.93

23.87

ug/l

0.60

427

3155

Allergic asthma (mode), excluding more controls

427

1.77

5.38

1.6

2.1

21.12

25.73

ug/l

0.43

422

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

259

2.03

5.38

1.8

34.61

25.35

ug/l

0.24

254

Alzheimer disease

103

1240

0.62

5.36

1.5

1.7

18.06

24.03

ug/l

1.46

1200

Alzheimer disease, including avohilmo

131

1435

0.66

5.36

1.5

1.7

17.03

23.56

ug/l

2.33

126

1392

Tic and related disorders

5.65

5.34

3.0

3.3

15.89

19.59

ug/l

—

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

11.62

5.33

2.0

1.5

13.00

19.12

ug/l

—

Wilms' tumor

4.83

5.33

6.0

1.8

29.23

15.86

ug/l

0.86

Conduction disorders

222

1326

1.40

5.29

1.9

18.04

24.76

ug/l

3.25

215

1300

Benign neoplasm: Other and unspecified parts of small intestine

5.08

5.28

2.7

1.3

14.58

15.80

ug/l

0.16

Care involving use of rehabilitation procedures

342

2498

1.30

5.26

1.9

25.74

22.65

ug/l

0.49

335

2447

Malignant neoplasm of other and ill-defined sites

+∞

5.25

1.0

0.0

26.13

—

ug/l

—

Epilepsy

213

1525

1.40

5.23

1.8

2.0

22.95

23.48

ug/l

0.04

207

1484

Benign neoplasm: Colon, unspecified

195

1384

1.42

5.15

1.7

1.9

26.06

23.67

ug/l

0.15

189

1351

Magnesium deficiency

10.86

5.14

1.8

2.0

14.71

16.78

ug/l

—

Ductal carcinoma of pancreas

4.64

5.10

1.9

1.7

18.01

18.31

ug/l

0.02

Other gastritis (incl. Duodenitis)

166

1146

1.46

5.10

1.5

1.9

17.08

23.91

ug/l

2.62

160

1117

Any dementia, excluding more controls

141

1448

0.67

5.09

1.5

1.8

18.58

23.58

ug/l

1.60

135

1408

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

10.17

5.04

5.1

1.4

13.14

16.28

ug/l

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

3.30

5.03

1.3

1.5

14.65

16.11

ug/l

0.33

Hypotension

122

795

1.54

4.98

1.7

1.8

25.11

23.87

ug/l

0.06

115

774

Obesity related asthma

212

1536

1.39

4.96

1.8

2.0

16.44

24.73

ug/l

4.63

206

1504

Abnormalities of heart beat

206

1474

1.39

4.91

1.8

1.9

25.12

23.90

ug/l

0.10

199

1436

Molar incisor enamel hypoplasia, with caries

4.42

4.85

10.7

5.2

31.83

21.70

ug/l

0.62

Ventral hernia

170

1191

1.43

4.85

1.7

2.0

46.49

23.03

ug/l

0.79

165

1160

Follow-up examination after treatment for conditions other than malignant neoplasms

267

1306

1.34

4.85

1.9

1.8

22.41

27.30

ug/l

0.54

259

1287

Gingivitis and periodontal diseases

619

2633

1.22

4.84

1.9

23.88

24.58

ug/l

0.09

603

2577

Inflammatory diseases of female pelvic organs

236

1310

1.36

4.79

2.0

1.9

21.46

24.40

ug/l

0.45

229

1285

Degenerative diseases of the nervous system

130

1447

0.67

4.75

1.5

1.7

17.04

23.46

ug/l

2.23

124

1403

Carcinoma in situ of skin of upper limb, including shoulder

3.99

4.73

2.0

1.2

47.79

15.04

ug/l

0.63

Other CVD

141

959

1.48

4.71

1.8

24.17

23.55

ug/l

0.03

134

933

Lack of expected normal physiological development

4.08

4.69

4.7

3.8

20.84

22.39

ug/l

0.19

DVT of lower extremities

136

920

1.49

4.68

1.7

1.9

17.79

24.08

ug/l

2.32

131

899

Headache

323

2096

1.29

4.62

2.0

1.9

25.48

24.27

ug/l

0.06

315

2054

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

14.54

4.62

2.6

1.2

21.01

21.84

ug/l

—

Spinal stenosis

396

2472

1.26

4.58

1.8

1.9

39.32

23.89

ug/l

1.20

385

2421

Malignant neoplasm of stomach

214

2.03

4.53

1.5

1.7

16.02

26.03

ug/l

0.89

209

Benign neoplasm: Skin of trunk

3.17

4.49

1.6

1.2

19.25

15.67

ug/l

0.25

Benign neoplasm: Adrenal gland

300

1.85

4.44

1.9

1.8

45.22

23.38

ug/l

0.48

294

Neuroendocrine tumor and carcinoma of rectum

7.98

4.44

2.7

1.7

14.51

14.53

ug/l

—

Carcinoma in situ of middle ear and respiratory system

4.46

4.43

1.5

1.7

14.38

14.36

ug/l

0.00

Other intervertebral disc disorders

554

2801

1.21

4.40

1.9

30.53

23.85

ug/l

0.60

543

2745

ILD medications: immunosuppressive drugs

340

2572

1.27

4.39

1.7

2.0

24.97

25.99

ug/l

0.12

328

2526

Other nutritional deficiencies

355

2754

1.26

4.36

1.7

2.0

25.09

24.30

ug/l

0.07

344

2693

Personal history of risk-factors, not elsewhere classified

4.62

4.32

1.5

2.4

30.75

20.38

ug/l

—

Myocardial infarction, strict

388

2265

1.25

4.31

1.7

1.9

25.16

24.56

ug/l

0.07

377

2220

Carcinoma in situ of other and unspecified genital organs

8.99

4.29

1.6

1.2

14.50

15.76

ug/l

—

Medical abortion

255

1046

1.33

4.22

1.8

1.9

33.33

21.58

ug/l

0.61

247

1026

Benign neoplasm of other and unspecified endocrine glands

516

1.62

4.21

1.9

36.03

22.10

ug/l

0.45

509

Exposure to unspecified factor

597

3887

1.19

4.17

1.8

2.0

24.02

24.73

ug/l

0.10

579

3813

Autoimmune diseases excluding thyroid diseases, strict definition

672

3164

1.19

4.12

1.8

2.0

26.63

25.32

ug/l

0.17

654

3109

Autoimmune diseases excluding thyroid diseases

690

3244

1.18

4.11

1.8

2.0

26.72

25.14

ug/l

0.21

672

3187

Benign neoplasm: Transverse colon

481

1.64

4.11

1.3

2.0

22.94

24.37

ug/l

0.10

474

Benign neoplasm: Endocrine pancreas

8.27

4.10

4.0

1.4

15.19

12.33

ug/l

—

Systemic connective tissue disorders

206

1537

1.34

4.09

1.7

1.9

19.23

23.03

ug/l

1.14

195

1504

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

8.15

4.08

2.0

1.4

11.45

18.92

ug/l

—

Personality disorders

118

799

1.48

4.08

1.5

2.1

21.10

23.58

ug/l

0.38

113

788

Other neurological diseases

502

3344

1.21

4.07

1.8

1.9

19.37

24.93

ug/l

2.74

488

3272

Benign neoplasm: Anus and anal canal

3.55

4.06

2.0

1.3

17.66

15.21

ug/l

0.22

Disorders of eyelid, lacrimal system and orbit

548

3592

1.20

4.03

1.8

1.9

22.28

25.17

ug/l

0.48

535

3514

Benign neoplasm: Liver/bile ducts

3.97

3.98

1.1

1.3

16.15

15.66

ug/l

0.05

Sleep disorders (combined)

641

3557

1.18

3.97

1.9

19.57

25.95

ug/l

3.01

628

3489

In situ neoplasms

222

1683

1.32

3.97

1.9

1.8

21.50

22.50

ug/l

0.15

215

1634

Melanoma in situ

2.84

3.96

1.7

1.2

19.22

15.77

ug/l

0.27

Cauda equina syndrome

3.71

3.94

1.6

1.5

18.72

17.73

ug/l

0.10

Sicca syndrome [Sjögren]

261

1.85

3.94

1.8

18.02

19.94

ug/l

0.23

256

Benign neoplasm: Skin of lower limb, including hip

3.67

3.93

3.1

1.3

18.48

15.27

ug/l

0.38

Nerve, nerve root and plexus disorders

687

3681

1.17

3.88

1.8

1.9

29.57

23.66

ug/l

0.68

672

3608

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

6.13

3.84

1.6

1.3

13.21

15.65

ug/l

—

Disorders of choroid and retina

562

3444

1.19

3.82

1.9

19.36

25.75

ug/l

3.57

545

3373

Carcinoma in situ of skin of lower limb, including hip

3.84

3.81

2.6

1.3

20.82

15.65

ug/l

0.30

Polyneuropathies and other disorders of the peripheral nervous system

162

1181

1.38

3.78

1.7

1.9

31.61

23.00

ug/l

0.45

150

1154

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

4.06

3.71

1.5

1.3

22.48

15.08

ug/l

—

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

6.82

3.69

2.1

1.3

14.47

17.28

ug/l

—

Melanoma of uvea

6.79

3.69

2.9

1.5

19.20

17.27

ug/l

—

Concussion

287

1963

1.27

3.68

1.7

2.0

31.77

26.97

ug/l

0.20

278

1931

Fracture of femur

177

1198

1.35

3.67

1.8

24.59

22.71

ug/l

0.13

170

1159

Symptoms and signs involving the nervous and musculoskeletal systems

357

2898

1.23

3.67

1.8

1.9

21.41

24.23

ug/l

0.31

349

2832

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

329

2593

1.24

3.66

1.9

2.0

17.65

26.32

ug/l

4.21

322

2548

Depression or dysthymia

483

2245

1.21

3.65

1.8

2.0

28.40

24.61

ug/l

0.37

474

2203

Obesity due to excess calories

248

1935

1.28

3.61

1.7

2.0

25.09

23.80

ug/l

0.09

243

1894

Sleep apnoea

608

3510

1.18

3.60

1.9

20.15

25.84

ug/l

2.27

597

3442

Used for control exclusion in common control thyroid runs

707

3076

1.17

3.60

1.8

2.0

21.53

24.76

ug/l

1.26

688

3021

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

3.07

3.54

1.3

1.5

14.29

15.79

ug/l

0.27

Other and unspecified polyneuropathies, also in other diseases

142

1026

1.39

3.53

1.6

1.8

34.09

22.38

ug/l

0.57

131

1000

Tic disorders

5.37

3.52

3.2

7.4

16.66

19.65

ug/l

—

Secondary thrombocytopenia

3.24

3.52

2.2

2.3

21.14

17.59

ug/l

0.32

Oxicams

183

773

1.35

3.50

2.0

1.7

26.01

25.29

ug/l

0.05

177

748

Salpingitis and oophoritis

526

1.55

3.48

1.8

1.9

17.83

23.97

ug/l

0.94

519

Other disorders of skin and subcutaneous tissue, not elsewhere classified

607

1.51

3.46

2.0

1.8

16.43

24.34

ug/l

2.53

597

Triptan medication for migraine, single purchase ok

244

2102

0.78

3.43

2.2

2.0

28.79

23.82

ug/l

0.20

239

2068

Migraine, single triptan purchase ok & required. ICD-code if available is included

244

2102

0.78

3.43

2.2

2.0

28.79

23.82

ug/l

0.20

239

2068

Cholelithiasis, broad definition with cholecystitis

555

3229

1.18

3.42

1.7

1.9

24.41

24.72

ug/l

0.03

537

3170

Stroke, including SAH

473

2935

1.20

3.42

1.9

21.26

25.43

ug/l

0.84

462

2869

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

5.09

3.39

1.8

1.3

13.68

11.77

ug/l

—

Perforation of tympanic membrane

352

1.66

3.32

2.6

1.9

27.47

26.63

ug/l

0.03

346

Other diseases of anus and rectum

193

1476

1.31

3.29

1.7

1.9

22.78

23.21

ug/l

0.03

183

1439

Autoimmune diseases

735

3256

1.15

3.29

1.8

2.0

24.39

25.18

ug/l

0.11

715

3199

Unspecified kidney failure

463

1.57

3.27

1.6

1.8

19.19

24.19

ug/l

0.63

453

Valgus deformity, not elsewhere classified

4.85

3.26

1.2

1.7

14.45

19.03

ug/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

4.80

3.25

2.3

1.3

12.99

15.89

ug/l

—

Streptococcal septicaemia

324

1.68

3.24

1.7

30.52

25.36

ug/l

0.21

319

Obesity

329

2666

1.22

3.20

1.8

2.0

26.11

24.29

ug/l

0.17

319

2605

Obesity and other hyperalimentation

330

2676

1.22

3.17

1.8

2.0

26.05

24.28

ug/l

0.16

320

2615

Anxiety disorders, excluding more controls

461

2572

1.19

3.17

1.9

2.0

23.95

24.46

ug/l

0.06

453

2518

Osteopathy in diseases classified elsewhere

4.64

3.14

1.3

1.5

24.87

15.35

ug/l

—

Kela-code for severe mental illness

192

1479

1.30

3.14

1.7

2.0

19.61

24.04

ug/l

1.07

187

1448

Insulin, fast-acting

230

1814

1.27

3.12

2.1

2.0

26.34

23.06

ug/l

0.22

222

1767

Paranoid personality disorder

2.84

3.10

1.9

1.7

18.53

20.18

ug/l

0.12

Diabetic nephropathy, excluding more controls

524

1.47

3.10

1.6

1.8

23.28

26.51

ug/l

0.25

516

Malignant neoplasm of nasal cavity and middle ear

5.21

3.09

2.1

1.7

13.34

18.55

ug/l

—

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

7.67

3.07

3.0

1.5

29.68

18.70

ug/l

—

Squamous cell neoplasms and carcinoma of cervix

7.66

3.07

1.8

1.6

14.36

17.79

ug/l

—

Cholelithiasis

529

3171

1.17

3.06

1.7

1.9

24.95

23.92

ug/l

0.10

512

3112

Benign neoplasm: Bladder

5.93

3.03

2.9

1.4

13.16

11.93

ug/l

—

Polyglandular dysfunction

10.49

3.01

4.4

1.2

12.40

16.94

ug/l

—

Benign neoplasm: Carotid body

10.43

3.01

2.2

1.0

8.60

12.40

ug/l

—

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

10.25

3.00

2.2

1.6

16.67

24.69

ug/l

—

Falls/tendency to fall

710

3100

1.15

2.99

1.9

2.0

19.61

25.82

ug/l

3.50

689

3047

Other systemic involvement of connective tissue

151

1135

1.33

2.97

1.7

1.9

18.36

23.12

ug/l

1.49

145

1109

Benign neoplasm of other and unspecified intrathoracic organs

3.21

2.95

1.8

1.6

23.49

18.19

ug/l

0.19

Malignant neoplasm of other and unspecified major salivary glands

6.98

2.90

2.0

2.2

14.42

12.36

ug/l

—

Phakomatoses, not elsewhere classified

4.16

2.89

2.3

2.2

13.53

20.21

ug/l

—

Disorders of lacrimal system

229

1827

1.26

2.87

1.5

1.9

20.77

23.83

ug/l

0.51

224

1785

Visual disturbances and blindness

297

2438

1.22

2.86

1.7

1.9

17.26

23.42

ug/l

4.33

286

2375

Dorsopathies

647

2874

1.15

2.83

2.0

1.9

22.08

23.93

ug/l

0.31

633

2816

Organic, including symptomatic, mental disorders

254

2262

0.81

2.82

1.6

1.8

24.67

24.16

ug/l

0.03

243

2200

Coronary revascularization (ANGIO or CABG)

371

2165

1.20

2.82

1.7

1.9

25.25

24.83

ug/l

0.04

357

2122

Functional dyspepsia

141

1059

1.34

2.81

1.7

2.0

19.98

22.68

ug/l

0.42

135

1035

Other diseases of urinary system

672

3306

1.14

2.81

2.1

1.9

19.37

26.25

ug/l

4.14

654

3246

Malignant neoplasm of nasal cavity and sinuses

4.03

2.80

2.0

1.7

15.85

17.14

ug/l

—

Gastric ulcer

127

940

1.36

2.80

2.1

1.9

21.70

24.72

ug/l

0.33

120

922

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

5.08

2.74

1.4

13.76

16.73

ug/l

—

Cervical disc disorders

244

1973

1.24

2.74

1.8

1.9

21.03

24.42

ug/l

0.76

237

1930

Disorders of psychological development

208

1.74

2.72

3.5

2.6

20.51

23.72

ug/l

0.55

203

Crowding of teeth, including avohilmo

113

1.98

2.71

5.9

2.9

26.04

27.22

ug/l

0.06

113

Carcinoma in situ of rectum

6.11

2.71

1.5

1.4

14.71

18.26

ug/l

—

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

6.08

2.71

2.8

1.4

29.49

19.47

ug/l

—

AV-block

130

881

1.35

2.70

1.9

1.8

18.13

25.65

ug/l

2.50

125

863

Presence of other functional implants

416

2501

1.18

2.69

1.9

22.22

25.39

ug/l

0.63

406

2449

Other/unspecified dorsalgia

212

1683

1.26

2.68

1.7

1.9

22.73

22.75

ug/l

0.00

207

1638

Explicit bacterial Sepsis

414

1.53

2.66

1.7

2.0

28.13

25.04

ug/l

0.14

406

Use of selegiline

202

0.34

2.65

2.1

1.6

40.97

18.36

ug/l

—

197

Delayed milestone in childhood

2.45

2.65

4.1

5.3

24.08

25.92

ug/l

0.18

Insulin, fast-acting or short human

231

1863

1.24

2.65

2.1

2.0

26.27

23.52

ug/l

0.18

223

1812

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

4.75

2.61

2.3

1.3

13.41

15.60

ug/l

—

Benign neoplasm: Appendix

4.74

2.61

1.6

1.4

15.26

16.79

ug/l

—

Stroke, excluding SAH

443

2820

1.17

2.59

1.8

1.9

19.35

23.54

ug/l

1.51

433

2756

Mood disorders, excluding more controls

563

2981

1.15

2.59

1.8

2.0

27.93

24.42

ug/l

0.39

551

2922

Dental pulpitis 4

692

3166

1.14

2.59

1.8

1.9

22.82

24.25

ug/l

0.24

675

3094

Benign neoplasm: Thymus

7.54

2.59

1.8

1.6

37.34

25.64

ug/l

—

Antihypertensive medication - note that there are other indications

259

1150

1.23

2.58

2.0

2.2

19.44

24.68

ug/l

1.72

253

1135

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

7.43

2.57

1.0

1.6

14.22

13.34

ug/l

—

Fatigue fracture of vertebra

5.61

2.56

1.3

1.8

12.74

23.16

ug/l

—

Carcinoma in situ of vulva

7.25

2.56

1.8

1.1

14.80

13.11

ug/l

—

Symptoms and signs involving emotional state

2.44

2.54

1.4

1.7

53.60

22.08

ug/l

0.58

Cerebral aneurysm, nonruptured

331

1.58

2.54

2.2

1.9

30.37

24.94

ug/l

0.12

325

Other viral diseases, not elsewhere classified

616

1.41

2.50

2.7

2.2

24.97

24.95

ug/l

0.00

610

Other and unspecified injuries of neck

4.45

2.49

1.9

2.9

15.06

15.85

ug/l

—

Motor disorders, excluding more controls

2.87

2.48

2.5

4.8

18.19

24.97

ug/l

1.23

Other systemic involvement of connective tissue (FG)

149

1143

1.30

2.48

1.7

1.8

18.42

24.34

ug/l

1.72

143

1117

Gout

225

1663

1.24

2.48

1.6

1.9

19.43

25.39

ug/l

1.71

220

1621

3.84

2.46

1.3

1.5

14.49

19.83

ug/l

—

Other crystal arthropathies

2.27

2.46

1.3

1.7

14.29

20.22

ug/l

1.07

Crystal arthropathies, rheuma endpoint

2.27

2.46

1.3

1.5

14.29

20.35

ug/l

1.51

Other and unspecified visual disturbances

334

1.56

2.45

1.7

1.9

15.21

23.62

ug/l

1.48

328

Budesonide

422

1.50

2.45

2.1

19.96

26.58

ug/l

0.50

415

Urticaria

131

997

1.32

2.44

2.0

2.2

19.74

23.41

ug/l

0.89

124

980

Hernia of abdominal wall

299

2503

1.20

2.42

1.9

34.95

23.72

ug/l

0.62

293

2441

Sleep apnoea, including avohilmo

617

3528

1.14

2.41

1.9

18.54

25.82

ug/l

5.04

604

3462

Nonpyogenic thrombosis of intracranial venous system

3.40

2.41

1.1

2.2

30.14

29.12

ug/l

—

Unspecified mental disorder

203

1635

1.24

2.40

1.7

2.0

20.30

23.56

ug/l

0.69

198

1602

Calcific aortic valvular stenosis, diagnosis (helper)

216

1717

1.23

2.38

1.7

1.8

25.92

23.59

ug/l

0.17

204

1667

Operations 2 for CAVS

216

1717

1.23

2.38

1.7

1.8

25.92

23.59

ug/l

0.17

204

1667

Benign neoplasm: Pharynx, unspecified

6.34

2.38

2.2

1.4

18.96

19.57

ug/l

—

Myocardial infarction, without ST-elevation

304

2354

1.19

2.38

1.7

1.8

20.08

23.90

ug/l

1.09

293

2295

Leiomyosarcoma

4.21

2.38

2.9

1.5

25.99

17.25

ug/l

—

Acute pharyngitis

390

1.51

2.37

2.4

2.2

16.11

21.00

ug/l

2.13

383

Benign neoplasm: Other/unspecified site

3.67

2.37

4.3

1.3

14.94

15.79

ug/l

—

Other diseases of upper respiratory tract

737

3421

1.12

2.36

1.9

21.43

26.18

ug/l

1.82

720

3352

Excessive, frequent and irregular menstruation

153

657

1.30

2.36

2.0

1.9

20.85

27.26

ug/l

0.69

145

637

Calcific aortic valvular stenosis

216

1719

1.23

2.36

1.7

1.8

25.92

23.59

ug/l

0.17

204

1669

Calcific aortic valvular stenosis, operated

216

1719

1.23

2.36

1.7

1.8

25.92

23.59

ug/l

0.17

204

1669

Schizophrenia

550

1.42

2.35

1.5

2.0

22.16

24.86

ug/l

0.22

541

Dental pulpitis 1

688

3171

1.13

2.34

1.8

1.9

22.87

24.24

ug/l

0.23

671

3098

Pain in thoracic spine

518

1.43

2.32

1.9

2.0

21.42

25.54

ug/l

0.34

511

Restless leg syndrome

444

1.47

2.32

2.4

1.9

16.97

25.14

ug/l

1.54

437

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

363

1.52

2.32

2.5

1.8

25.45

25.28

ug/l

0.01

358

Calcific aortic valvular stenosis, including rheumatic fever

216

1721

1.23

2.32

1.7

1.8

25.92

23.59

ug/l

0.17

204

1671

Injuries to the elbow and forearm

374

2894

1.17

2.30

2.1

1.9

21.35

24.25

ug/l

0.58

366

2823

Soft tissue disorders

650

2989

1.13

2.30

1.9

2.0

20.53

25.30

ug/l

1.92

635

2926

Thromboangiitis obliterans

4.77

2.29

2.0

1.3

21.08

15.01

ug/l

—

Brain meningioma, excluding all cancers (controls excluding all cancers)

2.38

2.29

3.1

1.3

17.23

15.94

ug/l

0.25

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

4.69

2.28

1.2

1.3

13.10

17.00

ug/l

—

Other disorders of skin and subcutaneous tissue

425

3370

1.16

2.28

1.9

24.11

23.70

ug/l

0.05

411

3298

Disorders of continuity of bone

285

1.59

2.27

2.0

1.8

19.02

20.83

ug/l

0.28

280

Malignant neoplasm of retroperitoneum and peritoneum

3.97

2.27

1.3

1.7

24.35

16.79

ug/l

—

Trichomoniasis

3.96

2.26

1.4

14.54

17.38

ug/l

—

Neurotic, stress-related and somatoform disorders

465

2875

1.15

2.26

1.9

2.0

23.88

24.61

ug/l

0.08

455

2814

Postmenopausal atrophic vaginitis

586

0.70

2.25

1.8

14.58

28.27

ug/l

2.32

568

Fasciculation

3.15

2.24

1.1

2.1

13.82

17.81

ug/l

—

Other external causes of accidental injury

548

2408

1.14

2.23

1.9

2.0

19.37

25.75

ug/l

3.09

535

2369

Delirium, not induced by alcohol and other psychoactive substances

516

1.42

2.19

1.7

1.8

23.84

25.51

ug/l

0.12

502

Chronic diseases of tonsils and adenoids

334

2479

0.85

2.19

1.9

2.1

19.81

26.82

ug/l

2.35

327

2440

Peripheral artery operations in Hilmo

643

1.37

2.18

1.9

1.8

34.60

21.91

ug/l

0.64

629

Melanocytic naevi of upper limb, including shoulder

3.36

2.18

2.8

1.3

59.36

15.18

ug/l

—

Malignant neoplasm of gum

3.82

2.18

1.1

1.6

13.76

18.07

ug/l

—

Diseases of pulp and periapical tissues, including avohilmo

684

3168

1.12

2.17

1.8

1.9

22.86

24.25

ug/l

0.23

667

3095

Malignant neoplasm of other and unspecified female genital organs

3.04

2.16

1.4

1.3

43.55

17.77

ug/l

—

Other disorders of ear

597

3528

1.13

2.15

1.9

21.05

25.75

ug/l

1.80

580

3459

Disorders of puberty

4.32

2.15

4.5

7.5

14.11

24.07

ug/l

—

Superficial injury of head

115

877

1.31

2.15

1.8

2.0

23.66

24.51

ug/l

0.07

109

851

Open wound of wrist and hand

249

2055

1.20

2.15

1.8

2.0

30.94

24.48

ug/l

0.54

244

2013

Visual disturbances

266

2232

1.19

2.14

1.7

2.0

17.42

23.72

ug/l

3.94

259

2174

Glomerular diseases

113

861

1.32

2.14

1.8

2.1

31.72

23.54

ug/l

0.71

104

844

Anxiety disorders

470

2913

1.14

2.13

1.9

2.0

23.77

24.75

ug/l

0.11

460

2851

Emergency coronary revascularization (for ACS)

426

2660

1.15

2.13

1.8

1.9

23.89

23.97

ug/l

0.01

411

2605

Urticaria and erythema

168

1346

1.25

2.13

1.9

2.1

20.21

24.32

ug/l

0.99

160

1324

Polymyalgia rheumatica

587

1.39

2.13

1.5

1.8

20.81

23.82

ug/l

0.42

576

Hypertensive heart and/or renal disease

187

1172

1.24

2.13

1.6

1.8

24.59

22.55

ug/l

0.14

181

1143

Accidents

546

2408

1.14

2.12

1.9

2.0

19.53

25.75

ug/l

2.95

534

2369

Speech disturbances, not elsewhere classified

347

1.51

2.11

2.5

1.8

15.77

26.77

ug/l

2.05

341

Nonalcoholic fatty liver disease

291

1.55

2.11

1.8

49.47

25.60

ug/l

0.37

286

Diabetic retinopathy, excluding more controls

146

643

1.28

2.10

2.1

1.9

20.72

25.32

ug/l

0.71

135

635

Menorrhagia

148

641

1.28

2.09

2.1

1.9

17.95

27.35

ug/l

1.38

141

621

Apocrine sweat disorders, other sweat gland disorders

5.13

2.08

1.0

1.5

13.52

19.89

ug/l

—

Hyperplasia of prostate

339

1651

1.17

2.08

2.1

1.9

26.19

27.45

ug/l

0.10

332

1618

Diaphragmatic hernia

226

1875

1.21

2.07

1.8

20.63

23.51

ug/l

0.43

219

1827

Other and unspecified primary disorders of muscles

3.57

2.07

1.3

2.3

24.21

18.00

ug/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

158

1263

1.25

2.06

1.8

2.0

18.75

23.99

ug/l

1.69

152

1236

Toxic effect of other and unspecified substances

3.53

2.06

1.1

2.9

14.59

15.51

ug/l

—

Other and unspecified diseases of spleen

4.12

2.06

1.0

1.5

12.95

14.23

ug/l

—

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

4.08

2.05

1.8

1.3

10.48

15.82

ug/l

—

Hypertensive Heart Disease

166

1090

1.25

2.04

1.6

1.8

25.32

22.48

ug/l

0.17

161

1061

Infarction of spleen

3.17

2.04

1.5

36.14

16.47

ug/l

—

Gout, FINNGEN

225

1871

1.21

2.03

1.6

1.8

19.43

23.72

ug/l

1.17

220

1822

Specific developmental disorder of motor function

2.54

2.03

2.5

4.2

18.19

25.34

ug/l

1.48

Benign neoplasm: Tonsil

2.67

2.02

2.1

1.9

12.15

17.63

ug/l

—

Any prescribed medicine buy

5.73

2.02

3.6

3.0

19.28

21.60

ug/l

—

Erectile dysfunction

535

1.39

2.01

1.7

2.0

14.85

24.95

ug/l

3.18

524

Foreign body in alimentary tract

193

1.67

2.00

2.4

1.8

15.29

20.59

ug/l

1.59

188

Exposure to other specified factors

403

3296

1.15

2.00

1.9

2.0

23.10

25.28

ug/l

0.26

386

3234

Fracture of lower leg, including ankle

312

2661

1.17

1.99

1.5

1.9

24.20

24.61

ug/l

0.04

300

2607

Fracture of shoulder and upper arm

201

1655

1.22

1.99

1.9

20.43

23.01

ug/l

0.62

194

1615

Other and unspecified urticaria

637

1.35

1.99

1.8

2.1

18.99

24.28

ug/l

0.97

627

Vascular dementia

364

0.55

1.99

1.1

1.6

16.85

23.16

ug/l

0.90

352

Microscopic polyangiitis

3.42

1.98

1.1

1.5

27.04

16.05

ug/l

—

External causes of morbidity and mortality

419

1826

1.15

1.98

1.9

2.1

24.68

23.44

ug/l

0.14

413

1799

Unspecified threat to breathing

3.38

1.97

2.1

2.0

14.80

22.60

ug/l

—

Benign neoplasm: Endocrine pancreas

3.04

1.96

4.0

1.6

15.19

15.64

ug/l

—

Benign neoplasm: Other parts of oropharynx

4.60

1.95

4.6

1.4

29.57

18.19

ug/l

—

Transient synovitis

4.60

1.95

5.6

1.9

13.85

19.67

ug/l

—

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

4.59

1.94

1.6

1.3

14.70

11.70

ug/l

—

Acute myeloid leukaemia, helper endpoint

4.59

1.94

1.6

1.3

14.70

11.70

ug/l

—

Pyoderma gangrenosum

3.81

1.94

2.5

1.5

21.21

20.58

ug/l

—

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

2.99

1.94

1.8

1.3

18.47

14.59

ug/l

—

Injury of nerves at forearm level

2.76

1.94

2.0

1.7

23.66

17.14

ug/l

—

Melanocytic naevi of scalp and neck

2.98

1.94

2.6

1.3

11.62

15.40

ug/l

—

Congenital malformations of the respiratory system

2.27

1.92

1.8

2.8

16.12

20.09

ug/l

0.74

Coronary angioplasty

298

1957

1.17

1.90

1.8

1.9

20.22

23.57

ug/l

0.90

289

1916

Dental caries 3

568

2585

1.12

1.90

2.1

1.9

22.99

25.39

ug/l

0.41

555

2526

Fibrosarcoma

3.24

1.89

1.1

1.7

12.56

17.30

ug/l

—

Viral and other specified intestinal infections

486

1.39

1.89

1.8

2.2

18.63

22.09

ug/l

0.68

479

Skin changes due to chronic exposure to nonionizing radiation

192

2191

0.83

1.88

1.9

1.8

21.32

23.55

ug/l

0.32

192

2123

Fistulae involving female genital tract

2.67

1.87

1.2

1.4

15.13

18.65

ug/l

—

Episodal and paroxysmal disorders

687

3172

1.11

1.86

1.9

21.33

25.84

ug/l

1.57

672

3108

Open bite

2.03

1.85

2.8

3.2

27.27

25.95

ug/l

0.06

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.58

1.84

6.7

1.6

14.73

17.16

ug/l

—

Motor disorders

2.41

1.84

2.5

5.1

18.19

24.46

ug/l

1.28

Heart failure and coronary heart disease

256

1617

1.18

1.84

1.5

1.8

19.83

23.69

ug/l

1.02

242

1573

Thrombotic microangiopathy

4.24

1.83

1.6

1.4

13.26

13.41

ug/l

—

Neurofibromatosis, type 1

4.23

1.83

1.2

1.6

16.15

18.28

ug/l

—

Benign neoplasm: Ascending colon

640

1.33

1.81

1.8

2.0

22.19

25.01

ug/l

0.25

626

Routine general health check-up of defined subpopulation

2.59

1.80

1.9

1.7

37.62

21.29

ug/l

—

Superficial injury of ankle and foot

311

1.48

1.80

2.1

18.72

19.82

ug/l

0.14

305

Other degenerative diseases of the nervous system

120

1149

0.79

1.79

1.5

1.9

17.42

25.73

ug/l

2.50

115

1122

Superficial injury of wrist and hand

598

1.34

1.78

1.6

2.1

16.00

23.87

ug/l

4.08

589

Pregnancy with abortive outcome

240

1057

1.19

1.75

1.7

1.9

22.74

21.53

ug/l

0.18

234

1035

Behavioural disorders

3.35

1.75

3.5

2.7

13.47

16.56

ug/l

—

Actinic keratosis

189

2149

0.83

1.74

1.9

1.8

21.43

23.66

ug/l

0.32

189

2081

Hypoplasia of dental enamel, prenatal , including avohilmo

3.00

1.74

3.9

5.9

26.73

24.76

ug/l

—

Intercostal neuropathy

2.96

1.73

1.1

1.6

16.93

17.01

ug/l

—

Moderate visual impairment, monocular

3.94

1.73

1.6

2.7

18.90

14.51

ug/l

—

Other forms of systemic lupus erythematosus

3.89

1.72

1.6

1.5

13.91

31.82

ug/l

—

Symptoms and signs involving appearance and behaviour

3.89

1.72

1.0

1.6

9.75

15.41

ug/l

—

Gonarthrosis, primary, with knee surgery

314

2948

0.87

1.71

1.6

1.8

20.47

24.37

ug/l

0.76

307

2882

Cholecystectomy

418

3270

1.13

1.71

1.9

23.46

23.96

ug/l

0.05

406

3198

Contraceptive management

110

981

0.79

1.71

1.9

2.0

16.87

24.60

ug/l

2.35

110

967

Carcinoma in situ of skin of trunk

2.31

1.71

1.7

1.2

16.60

15.51

ug/l

0.18

Lupus erythematosus

2.08

1.71

4.0

1.5

34.97

21.58

ug/l

0.33

Dermatitis and eczema

647

3844

1.10

1.67

1.8

1.9

30.02

23.73

ug/l

0.74

630

3769

Superficial injury of lower leg

111

877

1.27

1.67

1.8

2.1

19.93

23.35

ug/l

0.61

106

859

Other disorders of central nervous system

2.61

1.66

6.0

1.4

17.34

24.01

ug/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

3.18

1.66

4.8

1.3

12.58

15.57

ug/l

—

Disorders of parathyroid gland, other and/or unspecified

2.85

1.66

1.9

1.4

21.36

16.81

ug/l

—

Disorders of muscles

367

1.42

1.66

1.4

2.1

16.74

25.86

ug/l

1.47

362

Other immunodeficiencies

2.83

1.65

1.4

2.8

13.28

23.47

ug/l

—

Melanoma in situ of trunk

2.83

1.65

1.0

1.3

14.64

15.25

ug/l

—

Carcinoma in situ of skin of ear and external auricular canal

2.83

1.65

1.6

1.3

13.24

15.87

ug/l

—

Other disorders of eyelid

282

2356

1.16

1.65

1.9

1.8

25.32

24.11

ug/l

0.09

273

2293

207

2300

0.84

1.65

1.9

1.8

21.11

23.71

ug/l

0.42

207

2225

Chronic Coagulation defects

2.26

1.64

1.8

1.4

13.86

23.46

ug/l

1.25

Injuries to the hip and thigh

284

2250

1.16

1.63

1.7

1.9

24.02

23.59

ug/l

0.04

279

2186

Neurological diseases

529

2387

1.12

1.63

2.1

2.0

20.26

26.43

ug/l

2.77

518

2344

Cyst of kidney

294

1.47

1.63

1.5

1.8

40.64

23.41

ug/l

0.42

289

Glomerular disorders in diseases classified elsewhere

513

1.35

1.62

1.8

2.0

34.71

24.81

ug/l

0.63

505

Carcinoma in situ of prostate

3.64

1.62

2.0

1.4

30.07

16.26

ug/l

—

Benign lipomatous neoplasm

170

1412

1.21

1.62

1.9

20.72

22.98

ug/l

0.34

170

1378

Other inflammatory liver diseases

213

1.56

1.62

2.5

1.7

14.62

25.56

ug/l

1.18

208

135

1037

1.24

1.61

1.6

1.7

18.58

23.77

ug/l

1.30

130

1005

Nonsuppurative otitis media

525

1.32

1.60

2.8

2.2

20.40

24.84

ug/l

0.73

517

Genitourinary diseases

400

1770

1.13

1.60

2.1

2.0

23.61

27.32

ug/l

0.50

392

1741

Malignant neoplasm of eye and adnexa

2.73

1.59

1.3

2.0

19.53

14.34

ug/l

—

Memory loss

412

0.63

1.59

2.0

1.9

21.81

25.71

ug/l

0.25

405

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

3.03

1.58

1.3

1.4

12.32

15.81

ug/l

—

Von Willebrand disease

3.02

1.58

2.3

1.4

14.23

25.82

ug/l

—

Disorders of puberty, all

3.02

1.58

4.5

5.8

14.11

22.34

ug/l

—

Alzheimer’s disease (Early onset), excluding more controls

147

0.45

1.56

1.7

2.0

11.48

22.60

ug/l

—

140

Hypoplasia of dental enamel, prenatal

3.52

1.55

5.0

4.9

28.85

24.25

ug/l

—

Alzheimer’s disease (Early onset)

156

0.45

1.55

1.7

1.5

11.48

18.77

ug/l

—

150

Other chromosome abnormalities, not elsewhere classified

3.41

1.53

6.6

3.5

18.23

18.48

ug/l

—

Ocular pain

209

1.54

1.51

1.5

1.9

21.42

20.94

ug/l

0.03

204

Primary ovarian failure

2.87

1.51

2.0

1.6

15.77

28.84

ug/l

—

Combined immunodeficiencies

2.46

1.49

1.4

2.3

23.78

15.14

ug/l

—

Other arthrosis

283

2317

0.87

1.48

1.9

2.0

20.82

26.15

ug/l

1.74

277

2267

Valvular operations

788

1.26

1.45

1.5

2.0

30.89

24.34

ug/l

0.24

772

Diastasis of muscle

3.16

1.44

1.2

1.9

12.54

14.87

ug/l

—

Malignant immunoproliferative diseases

3.16

1.44

1.8

1.3

33.96

16.91

ug/l

—

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

3.16

1.44

1.0

1.4

15.24

16.66

ug/l

—

Abnormal findings on diagnostic imaging of breast

2.75

1.44

2.0

1.4

31.39

16.92

ug/l

—

Bruxism

2.74

1.43

1.3

1.6

16.21

25.57

ug/l

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.74

1.43

2.0

1.9

13.60

30.54

ug/l

—

Diseases of liver

204

1746

1.17

1.42

1.9

28.00

23.40

ug/l

0.28

199

1704

Retinal detachments and breaks

235

2034

1.16

1.42

1.8

1.9

18.60

24.24

ug/l

2.47

230

1981

Acute sinusitis

239

1929

1.16

1.42

1.8

1.9

19.20

23.98

ug/l

1.01

231

1891

Open wound of thorax

2.27

1.40

2.6

2.0

22.29

17.32

ug/l

—

Postpartum care and examination

108

0.47

1.40

1.1

1.8

15.24

20.19

ug/l

—

108

Type of accident

139

1153

1.21

1.39

1.8

2.0

18.39

24.11

ug/l

1.87

133

1131

Dermatophytosis

580

1.30

1.39

1.7

2.0

15.40

25.23

ug/l

3.29

572

Diseases of the eye and adnexa

476

2148

1.11

1.38

1.9

2.1

24.58

27.14

ug/l

0.33

465

2117

Malignant neoplasm of base of tongue

2.66

1.38

1.2

1.7

13.10

17.51

ug/l

—

Conductive and sensorineural hearing loss

529

3329

1.10

1.37

1.8

1.9

21.47

26.04

ug/l

1.42

513

3264

Dental caries 1 and operation codes

588

2749

1.10

1.37

2.0

1.9

20.51

25.96

ug/l

2.35

573

2689

Benign neoplasm: Prostate

2.98

1.36

1.4

1.3

17.17

15.80

ug/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

2.98

1.36

1.6

3.2

54.26

16.99

ug/l

—

Ischaemic Stroke, excluding all haemorrhages

400

2712

1.12

1.36

1.8

1.9

18.11

24.11

ug/l

3.82

391

2648

Injuries to the ankle and foot

329

2662

1.13

1.34

1.7

2.0

26.04

23.97

ug/l

0.10

321

2610

Acute upper respiratory infections of multiple and unspecified sites

391

2625

1.12

1.34

2.0

1.9

21.97

24.89

ug/l

0.35

383

2565

Carcinoma in situ of skin of scalp and neck

2.16

1.34

2.4

1.3

15.02

16.46

ug/l

—

Sequelae of infectious and parasitic diseases

232

1.47

1.34

1.5

1.8

51.20

20.67

ug/l

0.49

226

Exclusion endpoint for clefts

2.05

1.33

6.2

3.9

20.56

26.14

ug/l

0.62

Other menopausal disorders

567

0.78

1.32

2.4

1.9

18.21

28.13

ug/l

1.13

553

Benign lipomatous neoplasm of other sites/unspecified

368

1.36

1.31

1.5

1.9

23.38

22.42

ug/l

0.05

361

Disorders of ocular muscles, binocular movement, accommodation and refraction

220

1893

1.15

1.30

2.0

23.69

23.49

ug/l

0.02

215

1852

Other prurigo

2.38

1.30

2.4

1.4

60.53

17.81

ug/l

—

Squamous cell neoplasms and carcinomas of the skin

622

1.27

1.29

1.8

1.7

20.61

24.11

ug/l

0.39

603

Malignant neoplasm of floor of mouth

2.83

1.29

2.8

1.7

14.96

19.77

ug/l

—

Tumor necrosis factor alpha inhibitors

379

0.66

1.29

1.6

2.2

16.54

22.99

ug/l

0.77

373

Impaction of intestines

2.81

1.29

1.2

1.8

12.48

14.75

ug/l

—

Congenital malformations of pulmonary and tricuspid valves

2.81

1.29

2.8

7.5

22.94

20.05

ug/l

—

Carcinoma in situ of skin, other sites/unspecified

2.80

1.29

2.2

1.3

15.29

16.79

ug/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

293

1.40

1.28

1.8

18.77

21.58

ug/l

0.43

287

Other papulosquamous disorders

2.31

1.27

1.3

1.9

14.19

16.76

ug/l

—

Suggestive for eosinophilic asthma

370

1.36

1.27

1.6

1.9

14.48

25.86

ug/l

2.41

364

Carcinoma in situ of other and unspecified genital organs

2.30

1.27

1.6

1.5

14.50

21.44

ug/l

—

Schizoaffective disorder

194

1.50

1.26

1.2

1.7

32.52

19.36

ug/l

0.42

189

Speech and linguistic disorders

186

1.50

1.26

4.1

2.7

20.89

23.32

ug/l

0.32

181

Injuries to the abdomen, lower back, lumbar spine and pelvis

211

1819

1.15

1.26

1.7

1.9

16.03

23.06

ug/l

6.37

204

1766

Diseases of the ear and mastoid process

703

3283

1.08

1.26

1.9

21.48

26.10

ug/l

1.78

688

3219

Reimbursement for rheumatic diseases

249

2822

0.88

1.25

1.6

1.9

25.73

23.70

ug/l

0.22

241

2756

Leiomyoma of uterus

237

1174

1.15

1.25

1.9

20.67

25.04

ug/l

0.59

230

1151

Lung transplant status

2.43

1.25

2.5

1.7

11.29

18.68

ug/l

—

Lung transplantation

2.43

1.25

2.5

1.7

11.29

18.68

ug/l

—

Personal history of medical treatment

2.43

1.25

4.7

1.6

21.48

17.00

ug/l

—

Habit and impulse disorders

2.41

1.24

1.5

2.2

12.32

29.09

ug/l

—

Benign neoplasm: Skin of upper limb, including shoulder

2.41

1.24

1.3

14.98

15.34

ug/l

—

Accidental poisoning by and exposure to other gases and vapours

2.67

1.22

1.6

1.7

10.85

19.21

ug/l

—

Other and unspecified papulosquamous disorders

2.67

1.22

1.2

2.2

15.28

17.55

ug/l

—

Other or unspecified paralytic strabismus

2.66

1.22

1.0

1.7

14.35

13.82

ug/l

—

Carcinoma in situ of vulva

2.66

1.22

1.8

1.4

14.80

23.03

ug/l

—

Diseases of external ear

189

1633

1.16

1.21

1.7

2.0

17.83

23.93

ug/l

2.46

179

1592

Fracture of forearm

271

2247

1.13

1.21

2.0

1.9

21.09

24.52

ug/l

0.55

265

2191

Myocardial infarction, unclassifiable

113

1213

0.83

1.20

1.5

1.8

31.30

22.82

ug/l

0.47

107

1181

Pacemaker

224

1907

1.14

1.19

1.7

1.8

18.50

23.87

ug/l

3.07

213

1857

Artrosis, including avohilmo

471

2835

0.91

1.19

2.0

1.9

23.86

25.25

ug/l

0.17

466

2778

Inhalation and ingestion of food causing obstruction of respiratory tract

2.13

1.19

2.1

1.7

13.56

17.87

ug/l

—

Hypothyroidism due to medicaments and other exogenous substances

2.13

1.19

2.1

1.9

15.17

17.87

ug/l

—

Guillain-Barre syndrome

1.95

1.17

1.9

1.8

31.35

16.70

ug/l

0.43

Vascular dementia (undefined)

126

0.47

1.17

1.2

1.6

14.18

21.61

ug/l

—

121

HSIL lesion of the cervix uteri, vagina or vulva

316

1.36

1.16

2.2

1.8

62.11

22.25

ug/l

0.65

310

Malignant neoplasm of other and unspecified parts of mouth

2.54

1.16

2.0

1.6

15.09

15.34

ug/l

—

Chronic sinusitis

220

1929

1.14

1.15

1.8

2.0

16.02

25.77

ug/l

5.22

212

1888

Pseudomembranous colitis

2.52

1.15

1.2

2.3

11.60

16.72

ug/l

—

Benign neoplasm: Skin of eyelid, including canthus

651

1.25

1.15

1.9

22.30

24.22

ug/l

0.18

643

Lumbar disc prolapse

372

2673

1.11

1.14

1.8

1.9

34.99

23.87

ug/l

0.72

363

2623

Dental pulpitis 2

480

2244

1.10

1.14

2.2

1.9

23.15

25.46

ug/l

0.34

470

2190

Dental caries 3 and operation codes

597

2824

1.09

1.13

2.0

1.9

20.86

25.76

ug/l

2.00

582

2764

Other and unspecified spinal muscular atrophies

2.36

1.13

2.0

1.8

10.61

16.94

ug/l

—

Biological medication for rheuma

437

0.71

1.13

1.6

2.2

15.35

23.87

ug/l

1.40

428

Diabetic nephropathy

751

1.23

1.12

1.6

1.9

23.28

24.15

ug/l

0.07

728

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.34

1.12

1.1

1.3

64.44

15.37

ug/l

—

Vitamin D deficiency

2.01

1.12

1.5

15.86

17.97

ug/l

—

Selective serotonin reuptake inhibitors

629

3062

1.08

1.12

1.9

24.99

23.57

ug/l

0.18

616

3003

Dental operations

455

2129

1.10

1.11

2.0

1.9

21.94

26.54

ug/l

1.17

446

2081

Sensorineural hearing loss

507

3259

1.09

1.11

1.8

1.9

21.78

25.96

ug/l

1.18

491

3195

Blindness, monocular

2.29

1.11

2.1

1.6

11.66

15.33

ug/l

—

Injuries to the shoulder and upper arm

496

3821

1.09

1.10

1.8

1.9

21.55

25.28

ug/l

0.95

482

3746

Complications of internal orthopaedic prosthetic devices, implants and grafts

132

1120

1.18

1.10

1.7

1.8

29.52

22.80

ug/l

0.49

126

1094

Cervical root disorders

2.41

1.09

1.0

1.5

51.90

17.67

ug/l

—

Acute appendicitis

375

3212

1.10

1.09

2.0

1.9

26.84

24.77

ug/l

0.17

369

3152

HSIL lesion of the vagina

2.40

1.09

1.0

1.3

127.68

30.68

ug/l

—

Tularaemia

1.97

1.09

2.1

1.5

11.52

16.15

ug/l

—

Autoimmune diseases related-to ILD

471

3803

1.09

1.08

1.7

1.9

21.45

25.14

ug/l

1.07

454

3734

Other congenital malformations of tongue, mouth and pharynx

2.19

1.08

6.1

4.8

21.50

22.22

ug/l

—

Other disorders of veins

197

1726

1.14

1.07

1.9

21.91

25.30

ug/l

0.37

188

1687

Endovascular or surgical operations to intracerebral aneurysms

236

1.40

1.06

2.2

1.8

16.00

25.42

ug/l

0.97

231

Malignant neoplasm of bone and articular cartilage

2.15

1.06

2.6

1.7

12.09

18.47

ug/l

—

Benign neoplasm: Bladder

2.14

1.06

2.9

1.6

13.16

15.87

ug/l

—

Appendicitis, broad definition

405

3382

1.10

1.05

2.0

1.9

26.07

24.71

ug/l

0.11

399

3318

Lichen planus

516

1.26

1.05

1.9

1.8

14.56

25.07

ug/l

3.12

509

Vasomotor rhinitis (mode)

253

0.63

1.04

1.8

11.82

19.39

ug/l

6.44

247

Lateral epicondylitis

516

1.26

1.04

1.7

2.1

21.55

24.93

ug/l

0.28

508

Dental caries, including avohilmo

529

2492

1.09

1.04

2.2

1.9

23.38

25.66

ug/l

0.36

517

2434

Other sleep disorders

463

1.28

1.04

1.8

2.0

20.34

25.08

ug/l

0.36

457

Dental caries 1

529

2492

1.09

1.04

2.2

1.9

23.38

25.66

ug/l

0.36

517

2434

Monoplegia

1.97

1.04

1.6

1.8

24.15

15.97

ug/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.97

1.04

2.3

1.8

12.99

16.76

ug/l

—

Diseases of appendix

408

3399

1.09

1.04

2.0

1.9

26.01

24.70

ug/l

0.11

401

3335

Leisure time condition

651

1.23

1.04

1.4

2.0

18.20

23.74

ug/l

1.06

643

Other specified congenital malformation syndromes affecting multiple systems

1.97

1.04

7.2

4.3

22.21

27.43

ug/l

—

Benign neoplasm: Pharynx, unspecified

2.30

1.04

2.2

2.0

18.96

16.07

ug/l

—

Diabetes insipidus

2.29

1.03

1.4

1.7

32.03

16.99

ug/l

—

Disorders in reading

2.28

1.03

1.4

2.7

15.20

19.22

ug/l

—

Benign neoplasm: Other and unspecified parts of small intestine

1.85

1.03

2.7

1.4

14.58

16.07

ug/l

0.39

Oral lichen ruber planus, hypothyreosis or thyroxin

2.01

1.00

1.7

1.4

13.41

17.91

ug/l

—

Benign neoplasm of bone and articular cartilage

248

1.37

0.99

1.5

1.9

18.58

20.55

ug/l

0.28

243

Injuries to the knee and lower leg

697

3727

1.07

0.99

1.7

1.9

24.39

24.73

ug/l

0.05

677

3655

Other cataract

290

2024

1.11

0.99

1.7

1.9

21.18

26.65

ug/l

1.08

282

1985

Arthrosis

408

2449

0.91

0.99

1.9

2.0

20.05

26.25

ug/l

2.12

401

2396

Cardiomyopathies, Secondary/extrinsic

2.20

0.98

1.2

1.3

17.60

16.68

ug/l

—

Benign neoplasm: Other parts of oropharynx

2.19

0.98

4.6

2.1

29.57

17.13

ug/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

607

0.82

0.98

2.2

2.0

20.52

24.42

ug/l

0.48

597

Other congenital malformations of the digestive system

147

1.49

0.98

4.3

2.9

21.00

18.53

ug/l

0.59

147

Polyarthrosis

113

918

1.18

0.98

1.8

23.14

25.64

ug/l

0.24

107

893

Other appendicitis

292

1.34

0.97

1.9

2.0

15.87

23.76

ug/l

1.07

287

Benign neoplasm: Appendix

1.96

0.97

1.6

15.26

16.92

ug/l

—

Hypersomnia

1.96

0.97

3.1

2.0

17.21

17.47

ug/l

—

Other retinal disorders

405

2984

1.09

0.97

1.9

1.8

19.40

24.71

ug/l

2.25

389

2916

Polycystic ovarian syndrome

1.95

0.97

2.0

30.63

26.03

ug/l

—

Polycystic ovarian syndrome, broad definition

1.63

0.97

1.9

2.3

21.07

24.07

ug/l

0.17

Dental pulpitis 2, only avohilmo

490

2313

1.08

0.97

2.2

1.9

23.96

25.71

ug/l

0.24

480

2257

Finngen Rheumatological endpoints

570

3018

1.08

0.96

1.8

2.0

21.43

26.24

ug/l

1.39

558

2959

Intracranial injury

320

2810

1.10

0.95

1.8

1.9

22.34

23.38

ug/l

0.09

309

2748

Other predominantly sexually transmitted diseases, not elsewhere classified

337

1.31

0.95

1.7

2.0

55.38

20.76

ug/l

0.60

332

Palindromic rheumatism

1.91

0.94

1.4

1.9

72.29

16.89

ug/l

—

Persistent delusional disorders

242

1.37

0.94

1.4

1.8

16.16

23.77

ug/l

0.82

237

190

1487

1.13

0.94

1.6

1.8

18.40

23.89

ug/l

2.07

182

1445

Dyshidrosis [pompholyx]

1.90

0.94

1.3

1.9

11.03

16.95

ug/l

—

Diseases of male genital organs

397

1838

1.09

0.94

2.2

1.9

26.43

26.87

ug/l

0.04

392

1801

Viral infections characterized by skin and mucous membrane lesions

211

1877

1.12

0.93

1.8

2.0

17.36

23.29

ug/l

3.38

204

1837

Depression

510

3255

1.08

0.93

1.8

1.9

28.92

24.49

ug/l

0.48

499

3189

Other and unspecified tonsillitis

117

847

1.17

0.92

2.8

2.1

27.84

22.89

ug/l

0.34

117

836

Superficial injury of hip and thigh

561

1.23

0.92

1.6

1.8

23.82

23.39

ug/l

0.03

547

Spondylosis

334

2614

1.10

0.92

1.9

28.70

23.60

ug/l

0.45

326

2561

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.16

0.92

4.5

1.4

21.17

18.04

ug/l

—

Primary gonarthrosis, bilateral

285

2746

0.91

0.90

1.7

1.8

24.02

24.53

ug/l

0.05

276

2681

Arthropathy in ulcerative colitis

2.08

0.89

1.3

2.4

15.24

25.32

ug/l

—

Intracranial and intraspinal abscess and granuloma

1.92

0.89

1.4

2.0

15.75

16.43

ug/l

—

Family history of certain disabilities and chronic diseases leading to disablement

1.69

0.89

1.8

2.3

14.27

19.50

ug/l

1.35

Disorder of the sleep-wake schedule

1.92

0.89

1.4

2.8

13.29

23.13

ug/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

272

1.33

0.87

2.1

1.8

14.55

19.91

ug/l

2.16

267

Orchitis and epididymitis

485

1.24

0.87

1.6

1.9

17.87

24.90

ug/l

1.17

474

Arthropathies

471

2585

0.93

0.87

2.0

2.1

18.78

26.16

ug/l

5.10

461

2531

L04AA Selective immunosuppressants

100

850

1.18

0.87

1.6

2.1

29.03

24.01

ug/l

0.37

836

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

103

1055

0.85

0.86

1.7

2.0

41.53

24.15

ug/l

0.34

103

1036

Type 1 diabetes, definitions combined

216

0.65

0.86

1.9

2.7

13.46

22.18

ug/l

2.69

210

Glucosamine medication

271

2381

0.91

0.86

1.8

19.58

24.89

ug/l

1.96

266

2311

Anxiety (asthma-related co-morbidities)

233

1653

1.11

0.85

1.9

2.1

28.32

23.84

ug/l

0.33

227

1631

Granulomatous disorders of skin and subcutaneous tissue

1.67

0.85

1.4

1.9

40.08

21.04

ug/l

0.33

Carcinoma in situ of rectum

1.96

0.85

1.5

1.6

14.71

19.15

ug/l

—

Marginal zone B-cell lymphoma

1.96

0.85

1.3

1.6

28.55

16.91

ug/l

—

Colorectal adenocarcinoma

127

1103

1.15

0.85

1.7

1.8

19.41

23.31

ug/l

0.92

122

1078

Type 1 diabetes, strict (exclude DM2)

215

0.65

0.85

1.9

2.7

13.46

22.32

ug/l

2.75

209

HSIL lesion of the vulva

1.94

0.84

1.8

1.4

14.67

26.31

ug/l

—

Gonarthrosis,primary

533

3588

0.93

0.84

1.7

1.9

23.34

25.07

ug/l

0.30

519

3516

Disorders of the thyroid gland

560

3422

1.07

0.84

1.8

1.9

19.98

24.31

ug/l

2.36

547

3352

Endometriosis

124

637

1.16

0.83

1.8

1.9

17.45

27.26

ug/l

1.42

124

618

Pedestrian injured in transport accident

214

1.36

0.82

1.6

1.7

17.89

19.67

ug/l

0.14

209

Other and unspecified acquired haemolytic anaemias

1.89

0.82

1.5

1.7

20.87

17.35

ug/l

—

Other factor of the environment

1.89

0.82

2.7

2.1

12.95

17.66

ug/l

—

Autonomic disorders

1.65

0.82

1.7

1.5

19.50

16.86

ug/l

0.19

Other diseases of liver

718

1.19

0.81

2.0

41.30

24.16

ug/l

0.53

706

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.71

0.80

4.0

1.4

21.44

16.80

ug/l

—

Keratitis

175

1559

1.12

0.80

1.8

2.0

24.00

23.08

ug/l

0.08

169

1526

Contact with machinery

554

1.21

0.80

1.7

1.9

29.49

24.23

ug/l

0.15

546

Failure and rejection of transplanted organs and tissues

1.83

0.79

2.2

1.6

17.47

17.64

ug/l

—

Chronic hepatitis NAS

1.83

0.79

2.7

1.6

11.32

17.95

ug/l

—

CR(E)ST syndrome

1.83

0.79

1.3

12.23

17.72

ug/l

—

Other skin changes

757

1.18

0.79

1.8

1.9

17.35

23.71

ug/l

2.00

741

Maternal care for known or suspected abnormality of pelvic organs

259

0.75

0.79

1.6

2.0

20.75

19.77

ug/l

0.08

254

Type 1 diabetes, wide definition, subgroup 1

775

1.17

0.78

2.1

2.2

35.88

22.33

ug/l

0.42

765

Car occupant injured in other and unspecified transport accidents

592

1.20

0.78

1.8

2.0

33.77

23.80

ug/l

0.23

585

Noninfective enteritis and colitis

235

2131

1.10

0.77

1.8

2.0

19.42

23.28

ug/l

0.97

230

2079

Divergent concomitant strabismus

208

1.35

0.77

3.6

1.8

34.52

19.65

ug/l

0.47

203

Dermatitis herpetiformis

1.71

0.76

2.2

1.4

11.80

17.65

ug/l

—

False labour

263

0.76

1.4

2.1

14.11

21.74

ug/l

2.98

258

Fetus and newborn affected by maternal complications of pregnancy

2.11

0.75

8.2

6.8

30.96

24.17

ug/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

2.09

0.74

1.8

5.7

20.10

23.13

ug/l

—

Benign neoplasm: Spinal cord

2.09

0.74

3.8

1.3

15.57

14.64

ug/l

—

Mood [affective] disorders

566

3502

1.06

0.73

1.8

1.9

27.84

23.96

ug/l

0.45

553

3430

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.64

0.73

3.2

5.5

22.72

27.36

ug/l

—

Mood disorders

568

3510

1.06

0.73

1.8

1.9

27.81

23.94

ug/l

0.46

555

3437

Benign neoplasm of other and unspecified female genital organs

1.85

0.73

1.6

1.3

27.64

14.90

ug/l

—

Scissor bite

1.84

0.73

2.7

4.8

20.05

20.63

ug/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

529

1.20

0.73

1.9

2.0

54.25

20.12

ug/l

0.90

520

Disorders of sclera, cornea, iris and ciliary body

283

2601

1.09

0.73

1.8

1.9

22.82

23.15

ug/l

0.04

275

2540

Congenital malformations of the musculoskeletal system, not elsewhere classified

2.01

0.73

2.2

1.6

17.85

31.20

ug/l

—

Idiopathic gout

488

1.21

0.72

1.6

2.0

17.72

25.14

ug/l

1.31

481

Hyperkinetic disorders (excl. ADHD)

1.99

0.72

3.8

5.0

23.06

26.17

ug/l

—

Wet age-related macular degeneration

100

851

1.16

0.72

1.7

16.88

23.04

ug/l

2.23

823

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.58

0.71

3.2

5.3

22.72

26.79

ug/l

—

Otorrhagia

1.94

0.71

1.0

1.8

19.45

20.65

ug/l

—

Cystitis

486

2785

1.07

0.71

2.0

1.9

20.67

25.23

ug/l

1.35

476

2729

Congenital malformations of trachea and bronchus

1.94

0.71

1.0

3.0

9.74

16.48

ug/l

—

Cellulitis of external ear

1.93

0.71

2.8

2.2

16.01

18.43

ug/l

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

1.93

0.71

2.2

1.7

22.98

20.52

ug/l

—

LSIL lesion of the vagina

1.93

0.71

3.2

1.5

29.97

27.02

ug/l

—

Other joint disorders

514

2570

1.07

0.70

1.7

2.0

19.98

26.14

ug/l

3.19

504

2516

Foreign body on external eye

637

1.18

0.70

1.9

2.0

17.66

25.46

ug/l

1.77

627

Intussusception

1.56

0.70

4.7

2.0

13.95

23.91

ug/l

—

Carpal tunnel syndrome

327

2735

1.08

0.69

1.8

1.9

23.70

22.96

ug/l

0.09

318

2675

Other shoulder lesions

301

1.26

0.69

1.8

2.0

19.17

26.68

ug/l

0.70

295

Unspecified parasitic disease

1.87

0.68

1.2

1.6

24.25

16.00

ug/l

—

Recurrent and persistent haematuria

1.87

0.68

1.0

1.5

28.36

16.51

ug/l

—

Symptoms and signs involving speech and voice

170

1531

1.11

0.68

1.8

1.9

37.08

23.85

ug/l

0.39

161

1499

Meniscus derangement

373

2378

1.07

0.67

1.6

2.0

28.73

26.13

ug/l

0.15

364

2328

Dental caries 3, only avohilmo

558

2691

1.06

0.67

2.0

1.9

22.81

25.64

ug/l

0.50

545

2631

Other congenital malformations of intestine

1.80

0.66

3.8

2.9

26.32

19.40

ug/l

—

Xanthelasma of eyelid

1.80

0.66

2.0

1.5

19.21

18.93

ug/l

—

Other abnormal auditory perceptions

1.80

0.66

1.2

1.5

12.87

16.49

ug/l

—

Atopic dermatitis, strict definition

738

1.16

0.65

1.6

2.3

37.99

22.79

ug/l

0.60

725

Dental caries 1, only avohilmo

538

2595

1.06

0.65

2.0

1.9

22.99

25.91

ug/l

0.50

526

2536

Other and unspecified disorders of vitreous body

202

2199

0.91

0.64

1.9

29.73

23.80

ug/l

0.20

197

2151

Pedestrian injured in other and unspecified transport accidents

1.73

0.64

1.4

1.5

39.24

21.71

ug/l

—

Disorders of optic nerve and visual pathways

278

1.26

0.63

2.0

1.9

21.31

21.68

ug/l

0.02

273

Gestational diabetes (for exclusion)

365

0.81

0.63

1.7

2.0

17.03

21.96

ug/l

0.87

358

Malignant neoplasm of skin

416

2941

1.07

0.62

1.7

1.8

24.90

23.85

ug/l

0.12

409

2866

Benign neoplasm: Other/unspecified site

1.64

0.62

4.3

1.8

14.94

16.20

ug/l

—

Other and unspecified haemorrhagic conditions

1.64

0.62

1.4

25.24

20.76

ug/l

—

Long labour

352

0.79

0.62

2.1

1.9

21.05

21.49

ug/l

0.03

347

Other anxiety disorders

154

1231

1.11

0.62

1.9

2.1

25.24

23.75

ug/l

0.09

149

1214

Chronic myeloid leukaemia [CML], BCR/ABL-positive

1.68

0.61

1.0

2.1

15.24

16.98

ug/l

—

Superficial injury of neck

1.67

0.61

1.0

1.9

23.08

23.29

ug/l

—

Cardiodefibrillation

256

2364

1.08

0.61

1.9

1.8

24.01

23.96

ug/l

0.00

249

2309

Rheumatoid lung disease

0.00

0.61

0.0

1.5

—

14.71

—

Cardiomyopathy in other diseases

0.00

0.60

0.0

1.3

—

22.98

—

Otitis externa, unspecified

344

1.22

0.59

1.6

2.1

20.35

26.46

ug/l

0.51

339

Other and unspecified mental retardation

1.54

0.59

1.4

4.1

24.20

19.95

ug/l

—

Other disorders of binocular vision

0.00

0.59

0.0

1.4

—

21.84

—

Asymmetry of jaw

0.00

0.59

0.0

1.4

—

30.29

—

Cervicocranial syndrome

381

1.21

0.59

1.5

2.0

21.51

27.79

ug/l

0.63

376

Uterine polyps

299

0.77

0.58

1.6

1.8

34.66

20.59

ug/l

0.52

293

Diseases of the musculoskeletal system and connective tissue

305

1423

1.08

0.58

2.0

2.1

23.89

25.59

ug/l

0.15

300

1395

Chromosomal abnormalities, not elsewhere classified

1.51

0.58

5.9

5.2

26.14

20.51

ug/l

—

Sequelae of cerebrovascular disease

227

1838

1.08

0.58

1.7

1.8

18.38

23.97

ug/l

2.70

220

1789

Sulfasalazine

132

1187

1.11

0.58

1.9

2.0

21.37

24.14

ug/l

0.31

127

1162

LSIL lesion of the vulva

1.48

0.57

1.3

1.8

34.24

25.02

ug/l

—

Cerebral palsy

1.67

0.57

1.2

2.5

21.66

19.85

ug/l

—

Unspecified privation

383

1.20

0.56

1.6

1.8

26.23

24.99

ug/l

0.05

378

Impacted cerumen

429

1.19

0.56

1.4

2.1

16.44

25.57

ug/l

1.57

423

Pedal cyclist injured in noncollision transport accidents

356

1.21

0.56

1.6

1.9

17.56

23.85

ug/l

0.71

351

Granuloma annulare

1.59

0.54

1.3

1.8

15.50

23.37

ug/l

—

Polyhydramnios

1.58

0.54

1.0

2.1

11.08

21.71

ug/l

—

Acute laryngitis and tracheitis

245

1.25

0.53

2.2

46.59

21.78

ug/l

0.40

239

Rheumatoid arthritis, including avohilmo

195

1797

1.09

0.53

1.9

23.98

23.29

ug/l

0.06

190

1752

Portal vein thrombosis

1.46

0.53

1.7

1.6

20.51

17.97

ug/l

—

Iridocyclitis in diseases classified elsewhere

1.46

0.53

1.4

1.7

14.24

16.24

ug/l

—

Lichen planus, including avohilmo

760

1.13

0.52

1.8

2.0

14.51

23.66

ug/l

4.34

749

Ectopic pregnancy

433

1.18

0.52

1.9

2.1

17.48

22.11

ug/l

0.69

428

Combinations of oral blood glucose lowering drugs

187

1724

1.09

0.51

2.1

2.0

24.94

22.19

ug/l

0.35

181

1692

Dental pulpitis 4, only avohilmo

661

3301

1.05

0.51

1.7

1.9

23.27

24.44

ug/l

0.18

649

3224

All anxiety disorders

234

1750

1.08

0.51

1.9

2.1

28.24

23.91

ug/l

0.32

228

1723

Disorders of vestibular function (Vertigo)

254

2354

1.07

0.51

1.9

1.8

19.63

24.40

ug/l

1.42

249

2288

Statin medication

370

1956

1.06

0.51

1.9

26.38

24.65

ug/l

0.17

362

1922

Gonarthrosis

396

2402

0.95

0.51

1.7

2.0

23.49

26.20

ug/l

0.44

388

2350

Injury of muscle and tendon at hip and thigh level

358

0.81

0.50

1.8

31.82

23.88

ug/l

0.28

353

Unstable angina pectoris

235

2091

0.93

0.50

1.8

1.9

22.71

23.79

ug/l

0.15

225

2044

Other and unspecified paralytic syndromes

1.47

0.50

1.5

1.8

15.96

17.14

ug/l

—

Retained placenta and membranes, without haemorrhage

298

1.21

0.49

2.6

2.1

18.03

22.66

ug/l

0.85

293

Use of amantadine

1.53

0.48

1.3

1.4

19.88

17.24

ug/l

—

Basal cell carcinoma

335

2826

0.94

0.48

1.7

1.8

25.23

24.04

ug/l

0.12

328

2751

Pre-eclampsia or poor fetal growth

613

1.14

0.48

1.7

2.1

52.22

22.40

ug/l

0.41

603

Other bursitis of hip

1.49

0.47

4.4

1.7

17.74

18.17

ug/l

—

Other disorders of optic [2nd] nerve and visual pathways

200

1.25

0.46

1.8

23.69

20.74

ug/l

0.15

195

Other noninflammatory disorders of vagina

200

1.25

0.46

2.0

1.8

40.20

20.22

ug/l

0.43

194

Basal cell carcinoma, including avohilmo

344

2861

0.95

0.46

1.7

1.8

25.19

24.00

ug/l

0.12

337

2786

Varicose veins

376

2695

1.05

0.45

1.8

19.46

25.15

ug/l

2.38

367

2634

Type 1 diabetes

116

1053

1.10

0.45

1.9

2.1

35.57

23.21

ug/l

0.50

109

1030

Injuries to the wrist and hand

545

3782

1.04

0.45

1.7

2.0

24.84

24.65

ug/l

0.02

535

3706

Type 1 diabetes, wide definition

845

1.11

0.44

2.0

2.2

35.90

22.18

ug/l

0.44

831

Puerperal sepsis

384

0.83

0.44

1.9

2.0

107.83

24.27

ug/l

0.56

376

Complications predominantly related to the puerperium

577

0.87

0.44

1.9

2.0

73.91

21.96

ug/l

0.54

567

Polyp of the female genital tract

626

0.90

0.43

1.7

1.9

22.38

27.51

ug/l

0.44

606

Benign neoplasm of brain and other parts of central nervous system

230

0.78

0.43

2.7

1.7

15.45

21.63

ug/l

1.90

225

Transient ischemic attack

341

2681

1.05

0.43

1.6

1.9

18.58

24.47

ug/l

2.50

332

2617

Diseases of inner ear

305

2826

1.06

0.42

1.8

20.91

24.29

ug/l

0.84

299

2755

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

1.41

0.42

6.2

3.4

20.29

23.33

ug/l

0.37

Lifestyle-related condition

1.57

0.42

2.2

2.1

12.98

17.65

ug/l

—

Acute otitis externa, noninfective

1.41

0.42

2.8

1.7

15.46

16.14

ug/l

—

Ulcer of lower limb, not elsewhere classified

679

1.12

0.42

1.7

1.8

34.78

23.99

ug/l

0.41

663

Rheumatoid arthritis

185

1567

1.07

0.42

1.9

24.27

25.54

ug/l

0.12

180

1524

Generalized pustular psoriasis

0.00

0.41

0.0

1.7

—

16.76

—

Other disorders of optic disc

1.52

0.41

1.4

1.6

16.89

17.12

ug/l

—

Toxic effect of organic solvents

0.00

0.41

0.0

1.5

—

15.02

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.37

0.41

6.4

4.9

28.01

25.61

ug/l

—

Acute inflammation of orbit

0.00

0.41

0.0

1.7

—

16.52

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.00

0.41

0.0

5.6

—

16.30

—

Migraine without aura, drug-induced

0.00

0.41

0.0

1.4

—

29.01

—

Venous complications and haemorrhoids in pregnancy

0.00

0.41

0.0

2.8

—

31.81

—

Congenital malformations, deformations and chromosomal abnormalities

244

2201

1.06

0.41

1.8

2.0

27.70

23.50

ug/l

0.36

239

2156

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

0.00

0.41

0.0

1.7

—

15.93

—

1.48

0.40

1.8

2.1

11.16

17.63

ug/l

—

Reiter disease

0.00

0.40

0.0

2.2

—

16.29

—

Mesial bite

0.00

0.40

0.0

2.3

—

21.26

—

Neonatal jaundice from other and unspecified causes

1.32

0.39

3.5

5.3

28.14

25.58

ug/l

—

Endometriosis of rectovaginal septum and vagina

223

1.21

0.39

1.3

1.9

21.59

19.70

ug/l

0.10

218

Disorders of brain, other and unspecified

1.43

0.39

1.6

1.5

16.07

16.79

ug/l

—

Other injuries of upper limb, level unspecified

1.43

0.39

1.4

2.0

10.40

17.84

ug/l

—

Papulosquamous disorders

206

1934

1.07

0.39

1.7

1.9

21.04

23.78

ug/l

0.39

195

1897

Contact with blunt object, undetermined intent

0.00

0.39

0.0

1.6

—

17.13

—

Villonodular synovitis (pigmented)

0.00

0.39

0.0

2.3

—

17.59

—

Endometriosis ASRM stages 1,2

372

1.16

0.38

1.9

2.0

21.82

21.71

ug/l

0.01

366

Intentional self-harm by sharp object

1.39

0.38

1.4

1.9

10.28

25.26

ug/l

—

Melanocytic naevi, other sites/unspecified

247

0.81

0.38

3.1

1.7

37.07

24.08

ug/l

0.32

242

Other/unspecified enthesopathies, not elsewhere classified

337

1.16

0.36

1.5

2.0

35.17

26.22

ug/l

0.29

332

Pre-eclampsia or eclampsia

516

1.12

0.36

1.8

2.0

59.79

23.39

ug/l

0.42

507

Overjet

1.46

0.36

4.2

2.4

20.49

26.68

ug/l

—

Complications following abortion and ectopic and molar pregnancy

1.34

0.36

2.5

1.9

15.80

19.94

ug/l

0.48

Endometriosis ASRM stages 3,4

602

1.11

0.35

1.5

2.0

17.18

21.51

ug/l

0.79

590

Placenta praevia

1.40

0.35

1.2

1.9

15.71

20.86

ug/l

—

Accidental poisoning by and exposure to alcohol

1.37

0.34

1.8

2.0

19.41

17.27

ug/l

—

All dysplastic lesions of the cervix uteri

413

1.14

0.34

2.1

2.0

53.87

20.05

ug/l

0.64

406

Coxarthrosis, primary, with hip surgery

270

2687

0.95

0.34

1.6

1.8

22.44

24.43

ug/l

0.32

265

2611

Hereditary ataxia

1.34

0.34

1.5

1.6

15.30

17.26

ug/l

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

1.34

0.34

1.3

2.2

19.50

18.99

ug/l

—

Conotruncal defects

1.31

0.33

1.5

3.4

25.83

25.08

ug/l

—

0.69

0.33

2.2

2.3

17.58

24.09

ug/l

—

Dental pulpitis 1, only avohilmo

655

3315

1.03

0.32

1.7

1.9

23.18

24.46

ug/l

0.20

643

3237

Pre-eclampsia

445

1.12

0.32

1.9

2.0

66.64

21.75

ug/l

0.45

437

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

522

1.11

0.31

2.1

2.0

21.80

24.78

ug/l

0.20

515

Maternal care for other conditions predominantly related to pregnancy

301

0.85

0.31

1.8

2.0

18.80

22.15

ug/l

0.29

295

Contusion of toe(s) without damage to nail

1.30

0.30

3.1

1.9

11.42

23.76

ug/l

—

Use of galantamine

261

0.84

0.30

1.3

1.8

20.74

19.12

ug/l

0.10

255

Bitten or struck by other mammals

268

1.16

0.30

1.5

2.1

46.25

19.58

ug/l

0.39

263

Drug-induced cataract

1.31

0.30

1.4

1.6

14.21

18.58

ug/l

1.39

Fall on same level involving ice and snow

265

2769

0.96

0.29

1.8

1.9

20.42

23.92

ug/l

0.83

260

2700

Osteomyelitis

260

1.16

0.28

3.7

1.7

20.62

26.60

ug/l

0.51

255

Motor neuron disease

1.32

0.28

1.1

1.8

14.26

27.94

ug/l

—

Motor neuron disease (with DMD)

1.32

0.28

1.1

1.8

14.26

27.94

ug/l

—

Parapsoriasis

1.27

0.28

1.1

1.7

13.34

15.98

ug/l

—

Dental operations, only avohilmo

445

2357

0.97

0.27

1.9

22.16

26.51

ug/l

1.09

436

2304

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.25

0.27

1.4

1.7

22.88

22.98

ug/l

—

Systemic sclerosis (FG)

1.23

0.27

1.3

1.9

12.06

20.71

ug/l

—

Systemic sclerosis

1.23

0.27

1.3

1.7

12.06

18.83

ug/l

—

1.23

0.27

1.9

172.95

22.76

ug/l

—

Insulin, fast-acting (human)

442

1.11

0.27

1.8

24.12

24.15

ug/l

0.00

435

Coxarthrosis, primary

357

3209

0.96

0.27

1.8

23.40

24.40

ug/l

0.14

352

3132

Dislocation, sprain and strain of joints and ligaments at neck level

404

1.11

0.26

1.9

17.24

22.91

ug/l

0.79

397

Systemic sclerosis, icd10

1.20

0.26

1.3

1.7

12.06

19.88

ug/l

—

Burns and corrosions of external body surface, specified by site

367

1.12

0.26

1.8

2.0

37.31

23.35

ug/l

0.27

362

Normotensive glaucoma

362

0.88

0.25

1.6

1.8

25.72

25.30

ug/l

0.01

354

Pedestrian injured in collision with car, pick-up truck or van

1.22

0.25

1.3

1.7

12.34

18.95

ug/l

—

Haemorrhagic and haematological disorders of fetus and newborn

1.21

0.25

3.2

4.7

26.91

25.91

ug/l

—

Hypothyroidism, other/unspecified

491

3149

1.03

0.24

1.8

1.9

20.08

23.86

ug/l

1.82

477

3083

Pain in joint

308

1967

1.04

0.24

1.6

1.9

24.55

24.92

ug/l

0.03

303

1928

Second line medication for Crohn's disease

274

2640

1.04

0.24

1.7

2.0

24.52

24.22

ug/l

0.03

264

2588

Ankyloglossia

1.35

0.23

8.0

5.7

27.39

22.70

ug/l

—

Acute poliomyelitis

1.32

0.23

1.2

1.9

17.80

17.27

ug/l

—

Procedures for purposes other than remedying health state

1.32

0.23

1.8

1.7

94.51

23.16

ug/l

—

Plantar fascial fibromatosis

338

0.89

0.23

2.2

2.0

16.68

27.20

ug/l

1.52

332

Perioral dermatitis

1.25

0.22

2.2

1.8

13.69

24.65

ug/l

—

Postpartum haemorrhage due to anatomy

0.74

0.22

2.1

2.3

15.62

21.65

ug/l

—

Other symptoms and signs involving cognitive functions and awareness

255

2306

1.04

0.22

1.5

1.9

23.39

23.78

ug/l

0.03

249

2250

Migraine without aura

400

1.10

0.22

3.0

2.2

24.00

20.63

ug/l

0.16

394

Postpartum haemorrhage

348

0.90

0.22

1.8

2.0

24.28

22.54

ug/l

0.11

341

Malignant immunoproliferative diseases

1.22

0.22

1.8

1.6

33.96

16.97

ug/l

—

Polyarteritis nodosa and related conditions

1.22

0.22

1.0

1.9

13.04

16.97

ug/l

—

Degeneration of macula and posterior pole

297

2368

1.03

0.22

1.6

1.8

18.73

23.66

ug/l

1.89

287

2306

Transient global amnesia

410

1.10

0.22

1.8

1.9

17.22

25.12

ug/l

1.49

404

Disorders of muscle tone of newborn

0.00

0.21

0.0

2.5

—

29.97

—

Exposure to excessive natural heat

0.00

0.21

0.0

1.7

—

15.73

—

Malignant neoplasm of ureter

0.00

0.21

0.0

1.9

—

15.67

—

Crushing injury of lower leg

0.00

0.21

0.0

1.4

—

14.10

—

Other leukaemias of specified cell type

0.00

0.21

0.0

1.5

—

20.97

—

Gout due to impairment of renal function

1.19

0.21

3.8

1.6

14.04

16.10

ug/l

—

Benign neoplasm: Ciliary body

0.00

0.21

0.0

1.3

—

13.02

—

Benign neoplasm: Extrahepatic bile ducts

0.00

0.21

0.0

1.8

—

13.64

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.21

0.0

9.3

—

16.90

—

Hypertrophy of bone

0.00

0.21

0.0

1.7

—

11.72

—

Burn and corrosion of other internal organs

0.00

0.21

0.0

2.6

—

16.26

—

Maxillary hypoplasia

0.00

0.21

0.0

4.0

—

14.54

—

Toxic liver disease

1.19

0.21

1.0

1.6

15.45

17.79

ug/l

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.21

0.0

2.1

—

15.88

—

Congenital malformations of ear causing impairment of hearing

0.00

0.21

0.0

1.4

—

15.24

—

Acute epiglottitis

1.19

0.21

1.0

1.8

89.32

16.32

ug/l

—

Injury of blood vessels at neck level

0.00

0.21

0.0

1.2

—

14.05

—

Unspecified organic or symptomatic mental disorder

0.00

0.21

0.0

1.8

—

16.23

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

0.21

0.0

1.9

—

18.53

—

Sequelae of burns, corrosions and frostbite

0.00

0.21

0.0

1.5

—

20.83

—

Disorders of adrenal gland, other and/or unspecified

0.00

0.21

0.0

2.5

—

17.29

—

Drug-induced headache, not elsewhere classified

0.00

0.21

0.0

1.5

—

12.82

—

Maxillary prognathism

0.00

0.21

0.0

1.8

—

15.69

—

Mandibular hypoplasia

0.00

0.21

0.0

1.5

—

13.40

—

Androgenic alopecia

0.00

0.21

0.0

1.5

—

17.98

—

Use of teriflunomide

0.00

0.21

0.0

2.5

—

34.02

—

Disorders of vitreous body

260

2634

0.97

0.21

1.9

29.34

23.54

ug/l

0.26

253

2573

Lipomatosis, not elsewhere classified

0.00

0.21

0.0

1.2

—

22.98

—

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

0.21

0.0

1.7

—

15.52

—

Labyrinthine fistula

0.00

0.21

0.0

1.6

—

18.81

—

Other specified and unspecified disorders of choroid

0.00

0.21

0.0

1.8

—

13.22

—

Down's syndrome

0.00

0.21

0.0

2.3

—

24.54

—

Listeriosis

0.00

0.21

0.0

1.8

—

19.07

—

Personal history of allergy to analgesic agent

0.00

0.21

0.0

1.9

—

16.11

—

Dysplastic lesion of unknown severity of the cervix uteri

0.00

0.21

0.0

1.7

—

43.39

—

Premenstrual syndrome

0.00

0.21

0.0

2.1

—

23.02

—

Other congenital malformations of ear

0.00

0.21

0.0

1.9

—

35.58

—

Dysplasia of cervi uteri

453

0.92

0.21

2.0

48.26

24.63

ug/l

0.48

443

Preparation and fitting of bite rail to mouth

398

0.90

0.21

1.4

1.9

17.10

23.84

ug/l

1.10

392

Need for immunization against single bacterial diseases

0.00

0.21

0.0

3.2

—

23.89

—

Otorrhoea

0.00

0.21

0.0

2.8

—

17.52

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.21

0.0

1.4

—

14.93

—

Monocytic leukaemia

0.00

0.21

0.0

1.8

—

15.80

—

Thalassaemia

0.00

0.21

0.0

2.2

—

14.66

—

Other infective (teno)synovitis

0.00

0.21

0.0

1.6

—

18.27

—

Other and unspecified atrophic disorders of skin

0.00

0.21

0.0

1.3

—

14.55

—

Other assisted single delivery

0.00

0.21

0.0

1.2

—

32.00

—

Vestibular neuronitis

354

1.10

0.20

1.5

1.8

22.25

26.39

ug/l

0.29

349

Rosacea

387

0.90

0.20

1.7

1.9

14.29

23.39

ug/l

2.07

382

Qualitative platelet defects

0.00

0.20

0.0

1.4

—

18.80

—

Adult respiratory distress syndrome

1.25

0.20

1.5

1.6

13.88

15.72

ug/l

—

Abnormality of red blood cells

0.00

0.20

0.0

1.5

—

18.29

—

Acquired clawhand, clubhand, clawfoot and clubfoot

0.00

0.20

0.0

1.9

—

18.05

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

0.20

0.0

2.4

—

14.57

—

Benign neoplasm: Brain, unspecified

0.00

0.20

0.0

1.7

—

17.00

—

Open wound of neck

0.00

0.20

0.0

1.5

—

12.80

—

Other nonscarring hair loss

0.00

0.20

0.0

1.7

—

17.66

—

Unequal limb length (acquired)

0.00

0.20

0.0

2.7

—

22.61

—

Other overlap syndromes

1.25

0.20

1.0

1.5

14.10

20.50

ug/l

—

Calcific tendinitis of shoulder

197

0.86

0.19

2.2

1.9

46.17

29.18

ug/l

0.28

192

Traumatic subdural haemorrhage

711

1.07

0.19

1.7

1.9

17.18

25.96

ug/l

2.06

692

Lichen sclerosus et atrophicus

322

0.90

0.18

1.4

1.9

21.33

21.50

ug/l

0.01

317

Other and unspecified nail disorders

1.21

0.18

1.3

1.6

12.98

17.52

ug/l

—

Inguinal hernia, bilateral

658

1.06

0.18

1.8

20.53

22.20

ug/l

0.22

643

Other disorders of penis

507

0.93

0.17

2.0

20.36

24.48

ug/l

0.51

495

Sulfonylureas

238

1958

0.97

0.17

1.5

1.8

27.02

22.94

ug/l

0.36

227

1909

Hypothyreosis and Thyroxine purchase for inclusion criteria

503

3251

1.02

0.17

1.9

20.01

24.48

ug/l

2.09

488

3185

Unspecified fall

235

2402

0.97

0.16

1.5

2.0

20.89

23.07

ug/l

0.33

229

2336

Cardiomyopathy, Hypertrophic obstructive

1.14

0.16

2.0

1.4

18.97

18.94

ug/l

—

Obstructed labour due to malposition and malpresentation of fetus

319

0.92

0.15

2.7

2.0

21.34

23.65

ug/l

0.18

313

Angina pectoris

390

2576

1.02

0.15

1.7

1.9

27.72

24.95

ug/l

0.25

375

2524

Juvenile arthritis (FINNGEN)

0.81

0.14

2.7

3.0

86.54

21.92

ug/l

—

Glaucoma

325

2916

0.98

0.14

1.7

1.8

19.80

24.21

ug/l

1.44

315

2845

Dronedarone medication

139

0.86

0.14

2.3

1.7

13.92

35.52

ug/l

1.59

139

L04AX Other immunosuppressants

265

2585

1.03

0.14

1.7

2.0

24.78

24.28

ug/l

0.05

255

2534

Injury of eye and orbit

489

1.06

0.14

2.1

2.0

16.91

24.44

ug/l

1.49

483

Fissure and fistula of anal and rectal regions

120

1156

1.04

0.14

1.5

2.0

20.44

22.73

ug/l

0.33

120

1127

Diabetic retinopathy, strict definition

727

0.95

0.13

1.8

1.9

24.66

24.11

ug/l

0.05

709

Hypothyroidism, strict autoimmune, 3 medication purchases required

437

2926

1.02

0.13

1.9

19.62

24.47

ug/l

2.33

423

2864

Disorders of vitreous body and globe

271

2703

0.98

0.13

1.9

28.77

23.52

ug/l

0.24

263

2641

Primary open-angle glaucoma

173

1735

0.97

0.13

1.5

1.8

19.25

23.73

ug/l

0.90

167

1683

Other diseases of spinal cord

1.17

0.13

2.2

1.5

12.56

19.68

ug/l

2.11

Palmar fascial fibromatosis [Dupuytren]

104

1001

1.04

0.13

1.7

1.9

24.86

25.33

ug/l

0.03

973

Urolithiasis

199

1938

1.03

0.13

1.8

1.9

17.63

24.21

ug/l

3.54

194

1890

Pyogenic arthritis

306

1.08

0.13

1.5

1.9

25.28

26.61

ug/l

0.06

300

Other hearing loss

147

1490

0.97

0.12

1.8

1.9

17.50

23.70

ug/l

2.81

138

1448

Inguinal or femoral hernia, bilateral

668

1.05

0.12

1.8

20.54

22.13

ug/l

0.21

653

Acute upper respiratory infections

590

3642

1.01

0.12

1.9

22.55

25.24

ug/l

0.42

579

3565

Hypothyroidism, strict autoimmune

405

2634

1.02

0.12

1.8

1.9

19.44

24.18

ug/l

2.12

393

2585

Other malignant neoplasms of skin (=non-melanoma skin cancer)

350

2711

1.02

0.12

1.7

1.8

24.86

24.15

ug/l

0.07

344

2638

Other noninflammatory disorders of vulva and perineum

230

0.91

0.11

1.7

1.9

18.11

19.44

ug/l

0.21

224

Sequelae of injuries of upper limb

322

0.93

0.11

1.8

1.9

36.63

20.57

ug/l

0.56

317

Artificial joint operation, meniscal resection

560

3675

1.01

0.11

1.6

1.9

18.11

25.73

ug/l

5.68

549

3599

Colonic or urogenital fistula

132

1282

1.03

0.11

1.5

2.0

20.09

23.44

ug/l

0.57

132

1255

severe traumatic brain injury, does not include concussion

116

1124

1.03

0.11

1.8

17.55

22.87

ug/l

1.72

109

1095

Benign neoplasm of eye and adnexa

387

1.06

0.10

2.0

1.8

27.86

23.90

ug/l

0.14

381

Other arthritis (FG)

157

1530

1.03

0.10

1.8

2.0

28.35

25.15

ug/l

0.25

152

1495

Chronic suppurative otitis media, including avohilmo

270

1.07

0.10

3.6

2.0

23.28

28.45

ug/l

0.34

265

Psoriasis

130

1337

0.97

0.10

1.7

2.0

25.22

23.61

ug/l

0.13

124

1314

Bacterial, viral and other infectious agents

251

1.08

0.10

3.5

2.1

15.29

21.77

ug/l

1.68

246

Coronary artery bypass grafting

199

1548

0.98

0.10

1.7

1.8

30.67

23.52

ug/l

0.61

188

1511

Disorders of synovium and tendon

256

2349

0.98

0.10

2.1

2.0

23.27

24.53

ug/l

0.14

251

2299

Pregnancy hypertension

903

0.97

0.10

1.6

2.0

43.48

24.01

ug/l

0.36

887

Nystagmus and other irregular eye movements

1.11

0.10

1.6

2.9

15.56

20.99

ug/l

—

Gonarthrosis [arthrosis of knee](FG)

476

2839

0.99

0.09

1.7

1.9

22.45

26.54

ug/l

0.87

467

2782

Extrapyramidal and movement disorders

193

1971

0.98

0.09

1.9

23.14

22.65

ug/l

0.05

188

1917

Artificial joint re-operation

278

0.93

0.09

1.3

1.8

59.43

22.80

ug/l

0.70

272

Macular hole

233

1.07

0.09

1.4

1.7

12.91

27.24

ug/l

1.84

228

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.09

0.09

4.8

1.7

12.58

16.40

ug/l

—

Benign neoplasm: Skin of upper limb, including shoulder

1.07

0.08

1.3

1.5

14.99

16.67

ug/l

—

Congenital deformities of feet

1.05

0.08

2.3

2.4

84.80

17.05

ug/l

—

Optic atrophy

1.03

0.08

2.7

2.2

19.22

17.63

ug/l

—

Sacrococcygeal disorders, not elsewhere classified

0.83

0.08

2.4

1.8

14.14

24.59

ug/l

—

Primary open-angle glaucoma, strict

141

1439

0.98

0.08

1.5

1.8

20.08

22.42

ug/l

0.31

136

1394

Respiratory distress of newborn

1.06

0.08

7.0

5.3

29.10

24.08

ug/l

—

Other juvenile arthritis

0.86

0.07

1.3

3.5

99.26

22.44

ug/l

—

Endocarditis

143

0.91

0.07

1.8

17.59

35.06

ug/l

1.15

143

Burns and corrosions

482

1.04

0.06

1.9

2.1

34.24

24.07

ug/l

0.24

476

Glaucoma suspect

184

1869

0.98

0.06

1.8

1.9

20.12

22.60

ug/l

0.65

177

1814

Other diseases of hard tissues of teeth

327

2411

1.01

0.06

2.3

1.9

20.65

24.54

ug/l

1.24

321

2367

Sub-endpoint used in defining T1D endpoints

132

1275

1.02

0.06

1.9

2.0

33.13

23.88

ug/l

0.40

123

1247

Melanocytic naevi of trunk

414

0.97

0.05

3.3

1.9

33.56

25.27

ug/l

0.37

409

Gestational [pregnancy-induced] hypertension

483

0.97

0.04

1.6

2.1

18.19

20.47

ug/l

0.36

474

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

129

1309

0.99

0.04

1.8

2.0

21.91

23.48

ug/l

0.19

124

1282

Faecal incontinence

291

0.96

0.04

1.7

1.9

14.94

23.00

ug/l

3.04

285

Haemorrhage in early pregnancy

641

1.02

0.03

1.9

2.1

18.37

23.06

ug/l

0.63

631

Lichen ruber planus, wide definition including periferal and oral lichen planus

897

1.01

0.03

1.9

2.0

14.37

23.29

ug/l

5.19

883

Other osteochondropathies

231

1.04

0.02

1.4

1.7

25.31

18.93

ug/l

0.21

226

Diabetic retinopathy

174

1089

1.01

0.02

2.0

1.9

20.46

26.35

ug/l

1.23

162

1070

Other and unspecified rosacea

291

1.03

0.02

1.6

1.8

14.42

24.72

ug/l

1.67

286

Spirochaetal infections, other/unspecified

318

0.97

0.01

2.0

1.9

18.79

25.12

ug/l

0.72

311

Other disorders of the genitourinary system

462

1.02

0.01

1.4

1.9

18.58

21.96

ug/l

0.40

453

Diabetic neuropathy

535

0.98

0.01

1.6

1.9

44.15

24.32

ug/l

0.33

516

Retinal breaks without detachment

777

0.99

0.01

1.8

1.9

21.30

24.72

ug/l

0.39

765

Fibroblastic disorders

137

1377

0.99

0.00

1.8

1.9

22.64

25.24

ug/l

0.25

132

1339

Postpartum hemorraghe, all women as controls

363

0.99

0.00

1.8

2.0

24.28

21.91

ug/l

0.16

357

Other specific joint derangements/joint disorders

368

2469

1.00

0.00

1.6

2.0

23.65

26.25

ug/l

0.29

361

2417

Endometriosis of ovary

464

1.01

0.00

1.5

2.0

14.29

28.89

ug/l

1.87

452

Anomalies of dental arch relationship, including avohilmo

471

0.99

0.00

3.5

2.1

21.18

24.45

ug/l

0.37

464

Otosclerosis

308

1.01

0.00

1.7

1.8

19.45

24.14

ug/l

0.45

302

Endometriosis of pelvic peritoneum

392

1.01

0.00

2.0

2.1

22.41

27.45

ug/l

0.27

385

Spondylolisthesis/Spondylolysis

821

1.00

0.00

1.6

1.9

22.22

24.49

ug/l

0.21

807

Otalgia

244

0.98

0.00

2.1

2.2

25.54

20.20

ug/l

0.37

239

Spontaneous rupture of synovium and tendon

326

1.01

0.00

2.0

2.1

16.25

27.09

ug/l

1.63

321

Polyp of middle ear

0.00

0.0

1.3

—

17.11

—

Other hyperalimentation

0.00

0.0

3.0

—

16.34

—

Mandibular prognathia AND surgery (LeFortI or BSSRO)

0.00

0.0

1.8

—

12.45

—

Chronic drug-induced interstitial lung disorders

0.00

0.0

1.4

—

14.47

—

Plasmodium falciparum malaria

0.00

0.0

1.0

—

12.85

—

Other and unspecified pemphigus

0.00

0.0

2.0

—

20.38

—

Other and unspecified localized connective tissue disorders

0.00

0.0

2.2

—

14.14

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

0.0

1.3

—

14.45

—

Haemophilus septicemia

0.00

0.0

1.4

—

16.03

—

Unspecified transport accident

0.00

0.0

1.2

—

18.18

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.0

1.3

—

14.49

—

Kaposi sarcoma

0.00

0.0

1.3

—

16.66

—

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

0.00

0.0

3.6

—

19.32

—

Exposure to electric transmission lines

0.00

0.0

1.6

—

13.40

—

Injury of blood vessels at hip and thigh level

0.00

0.0

1.8

—

15.06

—

Other specific arthropathies, wide

1.01

0.00

1.4

1.9

72.29

20.96

ug/l

—

Calcification and ossification of muscle

0.00

0.0

1.9

—

16.18

—

Cyst of iris, ciliary body and anterior chamber

0.00

0.0

1.8

—

12.74

—

Other zoonotic bacterial diseases, not elsewhere classified

0.00

0.0

1.6

—

13.28

—

Other and unspecified syphilis

0.00

0.0

2.9

—

14.57

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.6

—

13.85

—

Brain astrocytoma

0.00

0.0

2.9

—

20.78

—

Phantom limb syndrome

0.00

0.0

2.3

—

13.01

—

Other and unspecified disorders of lacrimal system

0.00

0.0

1.4

—

16.77

—

Urticaria due to cold and heat

0.00

0.0

2.0

—

16.20

—

Small plaque parapsoriasis

0.00

0.0

1.4

—

15.37

—

Congenital hydrocephalus

0.00

0.0

3.1

—

18.84

—

Other leukaemias of specified cell type

0.00

0.0

1.4

—

24.40

—

Food allergy

0.00

0.0

1.0

—

11.26

—

Mechanical strabismus

0.00

0.0

2.7

—

24.07

—

Chronic inflammatory disorders of orbit

0.00

0.0

1.2

—

13.91

—

Granulosa cell carcinoma of ovary

0.00

0.0

1.4

—

19.45

—

Toxic encephalopathy

0.00

0.0

1.8

—

14.28

—

Monocytic leukaemia

0.00

0.0

1.4

—

11.69

—

Thoracic root disorders

0.00

0.0

1.3

—

14.72

—

Erythrasma

0.00

0.0

1.3

—

21.57

—

Pemphigus vulgaris

0.00

0.0

1.8

—

12.98

—

Toxic erythema

0.00

0.0

1.0

—

15.30

—

Classical phenylketonuria

0.00

0.0

1.4

—

18.93

—

Accidental poisoning by and exposure to pesticides

0.00

0.0

1.5

—

14.25

—

Adult-onset Still disease

0.00

0.0

1.5

—

22.27

—

Vertiginous syndromes in diseases classified elsewhere

0.00

0.0

1.0

—

15.96

—

Congenital lens malformations

0.00

0.0

1.4

—

15.69

—

Other infestations

0.00

0.0

1.4

—

15.32

—

Ascorbic acid deficiency

0.00

0.0

1.2

—

25.56

—

Pityriasis rubra pilaris

0.00

0.0

1.7

—

12.73

—

Hirsutism, drug-induced

0.00

0.0

1.4

—

19.45

—

Disorders of optic chiasm

0.00

0.0

1.0

—

13.77

—

Other conditions originating in the perinatal period

0.00

0.0

4.0

—

20.61

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.0

1.7

—

14.54

—

Exposure to noise

0.00

0.0

1.4

—

17.20

—

Contact with hypodermic needle

0.00

0.0

2.7

—

15.56

—

Intentional self-harm by other and unspecified firearm discharge

0.00

0.0

1.4

—

13.19

—

Embolic stroke with flimmer

0.92

0.00

1.6

16.48

18.63

ug/l

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

0.0

2.0

—

14.45

—

Rickettsioses

0.00

0.0

1.4

—

15.17

—

Other disturbances of cerebral status of newborn

0.00

0.0

3.6

—

22.23

—

Exposure to sunlight

0.00

0.0

1.8

—

14.40

—

Toxic effect of corrosive substances

0.00

0.0

2.8

—

13.70

—

Other and unspecified nonscarring hair loss

0.00

0.0

1.6

—

17.72

—

Cicatricial pemphigoid

0.00

0.0

1.8

—

13.47

—

Acanthosis nigricans

0.00

0.0

1.2

—

14.23

—

Femoral hernia, bilateral

0.00

0.0

1.3

—

13.81

—

Other degenerative disorders of eyelid and periocular area

0.00

0.0

1.9

—

17.75

—

Other disorders of breast and lactation associated with childbirth

0.00

0.0

1.9

—

37.43

—

Seborrhoeic keratosis

112

1120

1.00

0.00

2.1

1.9

16.98

22.73

ug/l

2.39

112

1093

Cystic fibrosis

0.00

0.0

1.4

—

15.59

—

Other perinatal haematological disorders

0.00

0.0

8.8

—

24.08

—

Urethral discharge

0.00

0.0

1.6

—

12.24

—

Defect, injury or illness of face

0.00

0.0

1.4

—

11.06

—

Acquired atrophy of ovary and fallopian tube

0.00

0.0

1.2

—

13.57

—

Henoch-Schönlein purpura nephritis (HSPN)

0.00

0.0

1.3

—

15.29

—

Hyposplenism

0.00

0.0

1.4

—

12.84

—

Use of pergolide

0.00

0.0

2.2

—

18.06

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

0.0

1.4

—

16.84

—

Relapsing fevers

0.00

0.0

2.0

—

18.09

—

Abnormal findings on antenatal screening of mother

0.88

0.00

1.6

2.7

10.49

24.46

ug/l

—

Traumatic spondylopathy

0.00

0.0

2.1

—

18.90

—

Familial erythrocytosis

0.00

0.0

1.4

—

14.28

—

Cerebral arteritis

0.00

0.0

1.9

—

17.05

—

Hypersensitivity pneumonitis due to organic dust

0.86

0.00

1.4

1.5

22.40

16.71

ug/l

—

Secondary sideroblastic anaemia

0.00

0.0

1.4

—

18.84

—

Inflammatory myopathy

0.00

0.0

2.1

—

14.54

—

Sickle-cell disorders

0.00

0.0

1.7

—

15.05

—

Benign neoplasm: Brain, unspecified

0.00

0.0

1.6

—

14.78

—

Benign neoplasm: Respiratory system, unspecified

0.00

0.0

2.4

—

13.74

—

Disorders of sexual preference

0.00

0.0

1.8

—

13.85

—

Cystic fibrosis, other manifestations/unspecified

0.00

0.0

1.4

—

16.73

—

Vaginal lichen planus

0.00

0.0

1.7

—

21.21

—

conjunctival scars

0.00

0.0

2.0

—

15.54

—

Drug-induced myopathy

0.00

0.0

2.0

—

16.36

—

Lichen planopilaris

0.00

0.0

1.6

—

20.05

—

Unspecified multiple injuries

0.00

0.0

1.5

—

16.10

—

Intermittent hydrarthrosis

0.00

0.0

2.0

—

13.22

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.00

0.00

3.5

1.5

18.67

18.63

ug/l

—

Aortic arch syndrome [Takayasu]

0.00

0.0

1.2

—

13.97

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

0.0

2.0

—

21.38

—

Posteruptive colour changes of dental hard tissues

0.00

0.0

3.6

—

18.86

—

0.00

0.0

1.2

—

12.77

—

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

0.00

0.0

2.0

—

18.49

—

Telogen effluvium

0.00

0.0

1.5

—

12.23

—

Other congenital malformations of female genitalia

0.00

0.0

1.3

—

35.59

—

Oesophagitis, drug-induced

0.00

0.0

2.2

—

14.39

—

Non-neuropathic heredofamilial amyloidosis

0.00

0.0

1.2

—

17.86

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

0.0

1.2

—

15.43

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

0.0

1.3

—

12.70

—

Open bite that required surgery (Lefort1 or BSSRO)

0.00

0.0

3.1

—

13.00

—

Vitreous prolapse

0.00

0.0

2.2

—

15.93

—

Labyrinthitis

0.00

0.0

1.8

—

12.92

—

Abnormalities of ear ossicles

0.00

0.0

1.8

—

12.34

—

Benign neoplasm: Connective and other soft tissue of pelvis

0.00

0.0

1.3

—

12.41

—

Neuralgic amyotrophy

0.00

0.0

1.4

—

24.48

—

Reduction defects of upper limb

0.00

0.0

3.4

—

25.10

—

Phantom limb syndrome with pain

0.00

-0.00

0.0

1.8

—

14.77

—

0.00

-0.00

0.0

2.0

—

18.54

—

Neurofibromatosis, type 2

0.00

-0.00

0.0

3.6

—

14.72

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Enolase.neuron specific [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS